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Cordyceps sinensis or "Dong chong xia chao" has been used as a traditional Chinese 
medicine (TCM) and tonic supplement for very long time. However, Cordyceps 
sinensis is rare and expensive, and difficult to standardize. An alternative, Cordyceps 
militaris is widely considered for consumption. In this project, the comparison of the 
anti-tumor proliferating activities of cultivated Cordyceps militaris and dried 
Cordyceps sinensis, with the use of water extracts of both fruiting body and mycelia, 
were carried out on liver cancer cells (hepatocellular carcinoma, HepG2) and control 
normal foreskin fibroblasts (Hs68). Fruiting body extract and mycelia extract of 
Cordyceps militaris were found to be more effective extracts and their anti-tumor 
proliferating efficiency was further evaluated on tumor cell lines H292 and Neuro2a, 
as well another control normal cell line WIL2-NS. 
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Comparative proteomic changes between the HepG2 and Hs68 cells after treatment 
of the two more effective Cordyceps extracts at their respective IC50 values were 
investigated. 2D gel electrophoresis and mass spectrometry were employed for 
separation and analysis of the total protein contents. Proteomic data was compiled to 
correlate the proteins involved in the anti-tumor proliferating activities of Cordyceps 
in treated tumor cells. In addition, western blotting using antibodies for different 
caspases were also performed. Results indicated that when HepG2 tumor cells were 
treated with the two Cordyceps extracts, the executioner caspases ( caspase-3 and -7) 

















caspase 的抗體進行檢查 O 結果顯示 caspase-3 和-7 有被活化，這表示該兩種蟲
草提取液能誘使癌細胞進行依賴 caspase 的細胞凋亡 o
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1. Literature review 
1.1. Introduction to Cordyceps 
Cordyceps sinensis also known as "Dong chong x1a chao" (summer-plant, 
winter-worm), is one of the most valued Chinese medicinal herbs. It is a unique 
blade-shaped fungus found primarily at high altitude on the Tibetan plateau. This 
fungus is parasitic on several species of caterpillar, and usually that of the moth 
Hepialidae. In late autumn, the fungal spores interacting with chemicals on the skin 
of the caterpillars release the fungal mycelia, which then infest the caterpillar and 
grow throughout the body cavity. By early summer of the following year, the fruiting 
body protrudes from the killed caterpillar's head. 
As a traditional Chinese medicine, Cordyceps goes to "lung" and "kidney" meridian. 
Nevertheless, base on the physiological and pathological concept, Cordyceps not 
only soothes the lung and nourishes the kidney, but also treats hyposexualities, 
hyperglycemia, hyperlipidemia, respiratory diseases, renal dysfunction and failure, 
dysrhythmia and cardiac diseases, hepatic diseases, night sweating and relieves 
fatigue and asthenia after severe illness. It is also used as a tonic supplement in 
chemotherapy and radiotherapy to relieve the side effects. Modernization of 
traditional Chinese medicine allows scientific studies focusing on the isolation and 
identification of Cordyceps bioactive ingredients, as well as characterization of their 
1 
biological and pharmacological effects. 
Two commonly used species of Cordyceps are Cordyceps sinensis "Dong chong 
chao" and Cordyceps militaris "Bei chong chao". Due to the scarcity and limited 
supply of wild Cordyceps sinensis, its prices skyrocket. Thus, Cordyceps militaris is 
often used as a replacement providing some of the bioactive ingredients, like 
cordycepin and adenosine, which are proved to have anti-cancer effect. Fig. 1.1a 
shows the morphology of dried Cordyceps sinensis while Fig. 1.1 b displays the 
cultivated Cordyceps militaris fruiting body and mycelia. 
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Fig. 1.1 a The morphology of dried Cordyceps sinensis 
Fig. 1.1 b The morphology of cultivated Cordyceps militaris fruiting body (left) and 
mycelia (right) 
3 
1.2. Ingredients of Cordyceps and their related biological activities 
1.2.1. Amino acids, peptides, proteins and polyamines 
In addition to all the essential amino acids, Cordyceps contains uncommon cyclic 
dipeptides, including cyclo-(Gly-Pro ), cyclo-(Leu-Pro ), cyclo-(Val-Pro ), cyclo-(Ala-
Leu), cyclo-(Ala-Vai), and cyclo-(Thr-Leu) (Zhu, et al., 1998). Small amounts of 
polyamines, including 1, 3-diamino propane, cadaverine, spermidine, spermine, and 
putrescine had been found. Several Cordycedipeptides had also been identified form 
the culture medium, named as 3-acetamino-6-isobutyl-2, 5-dioxopiperazine (ile-ala), 
3-isopropyl-6-isobutyl-2,5- dioxopiperazine (ile-val) and 3,6-di( 4-hydroxy)benzyl 
-2,5- dioxopiperazine (tyr-tyr) (Jia, et al., 2005). Cordyceps proteins identification 
and characterization could be categorized as proteomic studies. 
1.2.1.1. Proteins 
A fibrinolytic enzyme was purified from Cordyceps militaris using a combination of 
ion-exchange chromatography, gel filtration chromatography and FPLC. Purified 
enzyme had 52kDa molecular mass estimated by SDS-PAGE, fibrin zymography, 
and gel-filtration chromatography. De novo sequencing of theN-terminal was found 
to be ALTTQSNVTHGLATISLRQ, which is similar to the subtilisin-like serine 
protease PR1J from Metarhizium anisopliae var. anisopliase. The fibrinolysis pattern 
4 
indicated that the enzyme hydrolyzed the fibrin a-, y-y and ~-chain with decreasing 
priority. Fibrinogenolysis cleaved rapidly the fibrinogen Aa, B~, and y chains. The 
enzymatic activity was inhibited by Cu2+ and Co2+, but enhanced by Ca2+ and Mg2+ 
ions. Furthermore, the data on specificity for the chymotrypsin substrate, and 
fibrinolytic enzyme activity was potently inhibited by PMSF and APMSF indicated it 
was a chymotrypsin-like serine protease (Kim, et al., 2006). 
Similarly, Li, et al. purified a novel senne protease with fibrinolytic activity 
( Cordyceps sinensis protease -CSP) from the culture supernatant with molecular 
mass 31kDa. It was a single polypeptide chain and De novo sequencing of the 
N-terminal was found to be ALATQHGAPW. The effect of reducing agents, protease 
inhibitors and divalent cations on the enzyme activity indicated that CSP was a serine 
protease with a free cysteine residue near the active site. It hydrolyzed fibrinogen, 
fibrin and casein with a high efficiency but not bovine serum albumin and human 
serum albumin. CSP was found to be a plasmin-like protease, but not a plasminogen 
activator, and it preferentially cleaved the a-chain of fibrin and the Aa chain of 
fibrinogen (Li, et al., 2007). 
Lectins/ hemagglutinins are non-immunogenic origin proteins and with carbohydrate 
binding specificity, but the relationship between their catalytic reaction and the 
carbohydrate binding activity is poorly understood. A mushroom lectin, designated 
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CML, has been purified from ascomycete Cordyceps militaris with a molecular mass 
of 31.0 kDa. It exhibited hemagglutinating activity in mouse and rat erythrocytes, but 
not 1n human ABO erythrocytes. Hemagglutination was inhibited by 
· sialoglycoproteins, but not by mono- or disaccharides, asialoglycoproteins, or 
de-0-acetylated glycoprotein. Circular dichroism spectrum analysis revealed that 
CML comprised 27% a-helices, 12% ~-sheets, 29% ~-turns and 32% random coils. 
Its binding specificity and secondary structure were similar to those of a fungal lectin 
from Arthrobotrys oligospora. However, the N-terminal amino acid sequence of 
CML differed greatly from those of known lectins by low homology reported after 
BLAST search. Furthermore, CML exhibited mitogenic activity against mouse 
splenocytes (Jung, et al., 2007). Recently, a report revealed that Cordyceps militaris 
hemagglutinin differed form other ascomycete hemagglutinin in various biochemical 
characteristics. Chemical modification of tryptophan and tyrosine residues had no 
effect on it. The hemagglutinin exhibited some anti-proliferating activity against 
hepatoma cells (HepG2) and inhibited HIV-1 reverse transcriptase. However, it did 
not exhibit antifungal activity, ribonuclease activity, mitogenic activity towards 
splenocytes, or nitric oxide inducing activity towards macrophages. Such results did 
add information pertaining to agglutinins from ascomycete and medicinal 
mushrooms (Wong, et al., 2009). 
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1.2.2. Saccharides and sugar derivatives 
Saccharides and sugar derivatives such as d-mannitol were identified and their 
pharmacological activities have been reported. A group of polysaccharides had 
gained more attention. 
1.2.2.1. Polysaccharides 
An exopolysaccharide fraction (EPSF) has been obtained from the culture medium 
with ethanol precipitation form an anamorphic strain of Cordyceps, and its effect on 
immunocyte activity of H22 tumor (mouse hepetoma cell line) bearing mice was 
investigated. EPSF significantly inhibited the H22 tumor growth, and elevated 
immunocyte activity. It enhanced the phagocytosis capacity of peritoneal 
macrophages through promoting TNF -a expression. Furthermore, it enhanced the 
proliferation ability of spleen lymphocytes and corresponding cytotoxicity, through 
counteracting the decline of cytokines TNF-a and IFN-y production in the tumor 
bearing mice (Zhang, et al., 2008). Such EPSF could lower the expression of 
proto-oncogene c-Myc, c-Fos and Bcl-2, as well as vascular endothelial growth 
factor (VEGF) in the livers and lungs of tumor bearing mouse. The inhibitory effect 
on liver and lung tumor growth suggested that ESPF might be a potential adjuvant in 
cancer therapy (Yang, et al., 2005; Zhang, et al., 2005). 
A polysaccharide has been isolated form Cordyceps sinensis with molecular weight 
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'""210 kDa, and contained glucose, mannose and galactose in a ratio of 1: 0.6: 0.75. It 
had strong anti-oxidative activity that it protected the cultured rat 
phenochromocytoma PC12 cells against hydrogen peroxide (H20 2)-induced insult. 
Moreover, it significantly attenuated the changes of glutathione peroxidase and 
superoxide dismutase activities in H20 2-treated cells, and thus protected against the 
free radical-induced neuronal cell toxicity (Li, et a!., 2003). A cell wall 
polysaccharide was also obtained from · Cordyceps . . sznenszs mycelia. Such 
Cordyglucan was found to exhibit potent anti-tumor activity, which could be 
correlated to their (1 ~3)-beta-d-glucan linkages (Yalin, eta!., 2005). 
Different polysaccharide fractions were isolated from Cordyceps militaris. Their 
molecular weight, sugar composition and structure were investigated. The 
relationship between polysaccharide structure and biological activities including 
anti-inflammation and anti-oxidation was also studied (Yu, et a!., 2004a, Yu, et a!., 
2004b, Yu, et al., 2007). 
Focusing on hypoglycemic activity, a neutral polysaccharide (CS-F30) exhibited 
higher hypoglycemic activity than its crude polysaccharide (CS-OHEP) in 
streptozotocin- induced diabetic mice as a result of intraperitoneal (i.p.) injection 
(Kiho, et al., 1993). Administration of CS-F30 to normal mice significantly increased 
the activities of hepatic glucokinase, hexokinase and glucose-6-phosphate 
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dehydrogenase, although the glycogen content in the liver was reduced. Moreover, 
CS-F30 lowered the plasma triglyceride level and cholesterol level in mice (Kiho, et 
al., 1996). 
1.2.3. Nucleosides 
Nucleosides are one of the maJor components In Cordyceps. More than 10 
nucleosides and nucleobases had been discovered In Cordyceps. Using different 
chromatographic, mass spectrometric methods and also capillary electrophoresis for 
separation and determination, they were analyzed qualitatively and quantitatively (Yu, 
et al., 2006; Guo, et al., 2006; Huang, et al., 2003; Li, et al., 200la). There was a 
great variation in the nucleoside content of different sources of Cordyceps (Li, et al., 
2001a, Li, et al., 2001b). Among those nucleosides, cordycepin and adenosine were 
suggested to be the markers for quality control of Cordyceps as they provided a 
means of discriminating between Cordyceps militaris and its substitutes (Yu, et al., 
2006). These two nucleosides have been the foci for researchers studying their 
biological activities. 
1.2.3.1. Cordycepin 
Cordycepin (3 '-deoxyadenosine ), a derivative of the nucleoside adenosine with the 
absence of oxygen in the 3' position of its ribose entity, was reported of possessing 
many pharmacological activities including anti-cancer, antimetastatic, 
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immunomodulatory, anti-inflammatory, anti -oxidant, anti -aging, neuroprotecti ve, 
renoprotective, hypolipidaemic, hypoglycaemic and anti-microbial effects. 
For the anti-tumor activity, orally administrated cordycepin inhibited the growth of 
B 16 melanoma (B 16-BL6) cells inoculated into footpad of mice. The weight of the 
primary tumor lump was significantly reduced without any loss of bodyweight or 
systemic toxicity (Yoshikawa, et al., 2004). Researches concerning the anti-cancer 
effect of cordycepin have been carried out on various cancer cell lines. For example, 
the apoptotic effect of cordycepin in OEC-M1 human oral squamous cancer cells 
(Wu, et al., 2007), and in MA-10 Mouse Leydig Tumor Cells. The tumor cells 
apoptosis was characterized by the cellular rounding-up, plasma membrane blebbing, 
DNA fragmentation, and/ or caspase cascade activation. The growth of mouse 
melanoma (B16-BL6), mouse Lewis lung carcinoma (LLC) and human 
promyelocytic leukemia (HL60) cells was inhibited by cordycepin through adenosine 
A3 receptors stimulation using selective adenosine receptor agonists and antagonists 
(Nakamura, et al., 2006; Yoshikawa, et al. 2007). The downstream signal pathway 
was further elucidated in B 16-BL6 cells, such that stimulation of adenosine A3 
receptor by cordycepin was followed by the Wnt signaling pathway, including 
GSK-3 (3 activation and cyclin D1 inhibition (Yoshikawa, et al., 2008). Besides, 
cordycepin as a polyadenylation inhibitor, inhibited RNA synthesis and cell growth 
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in the multiple myeloma cell line (MM.l S) (Chen, et a/., 2008). It has also been 
demonstrated that cordycepin could modulate the polyadenylate polymerase (PAP) 
activity early in response to the treatment leading to anti-proliferation (Thomadaki, et 
a/., 2005; Thomadaki, eta/., 2008). 
Ho, et al. investigated the anti-inflammatory effect of cordycepin 111 
lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage cells, such that 
cordycepin suppressed the production of inflammatory mediators including NO, 
inducible nitric oxide synthase (iNOS), cycloxygenase-2 (COX-2) and cytokine 
TNF- a. The molecular mechanism appeared to involve the inhibition of Akt and 
p38 phosphorylation, which in tum suppressed nuclear factor-KB (NF-KB) activation 
(Kim, et al., 2006). Another study found that cordycepin specifically blocked 
chemokine epithelial neutrophil activating peptide 78 (ENA-78) production, and 
inhibited p3 8/JNK and AP-1 activation in the inflammatory signaling pathway which 
in tum reduced MMP production in inflammatory cascade (Noh, et al., 2009). 
Regarding the anti-oxidation effect, cordycepin could prevent the cell death in clonal 
rat pheochromocytoma cells (PC 12h) in exposure to high oxygen atmosphere, such 
that the oxidative stress was mediated by reactive oxygen species (Kubo, et al., 
1996). 
In another study, Cordycepin could inhibit collagen-induced platelet aggregation 
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dose-dependently with the presence of two aggregation-inducing molecules, 
cytosolic free Ca2+ and thromboxane A2. Its inhibitory effect might be associated 
with the down-regulation of intracellular Ca2+ and the elevation of 3 ',5 '-cyclic 
adenosine monophosphate I 3',5'-cyclic guanosine monophosphate (cAMP/ cGMP) 
production (Cho, et al., 2007). 
1.2.3.2. Adenosine 
Adenosine elicits its physiological responses by activating four G-protein coupled 
adenosine receptors: Al, A2A, A2B and A3. Since each of these receptors has a 
unique physiological profile and a particular affinity to its ligand, the inflammatory 
state is determined by both extracellular adenosine concentrations and by the 
distribution and expression levels of its receptor. Thus adenosine exhibits modulating 
effects on immune system. In the following paragraph, it would focus on discussing 
the general features of cytotoxicity of adenosine in killing the target cells by 
apoptosis. 
Extracellular adenosine has been shown to induce apoptosis in a variety of cells, but 
the molecular mechanisms were quite complicated and diverse. Generally, they could 
be classified via an extrinsic pathway linked to those adenosine receptors and an 
intrinsic pathway linked to adenosine uptake into cells following the ensuing 
signaling cascades. Relating to the extrinsic pathway, report suggested the induction 
12 
of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A3 receptor 
agonists as well as the receptor-mediated Ca2+ influx (Kohno, et al., 1996). 
Adenosine reduced viability of RCR-1 rat astrocytoma cells by activating caspase-9 
and -3. However, adenosine-induced RCR-1 cell death was significantly inhibited by 
8-CPT, an antagonist of A1 adenosine receptors, and forskolin, an adenylate cyclase 
activator. This raised the possibility that a decrease in intracellular cAMP is a critical 
factor to induce RCR-1 cell death for extrinsic pathway via A1 adenosine receptors. 
Besides, adenosine-induced cytotoxicity was inhibited by dipyridamole, an inhibitor 
of adenosine transporter, and AMDA, an inhibitor of adenosine kinase. This 
suggested the participation of the intrinsic pathway relevant to adenosine uptake into 
cells through adenosine transporters and the ensuing conversion to AMP by 
adenosine kinase, causing AMPK activation (Sai, et al., 2006). 
Apoptotic cell death was observed in Caco-2 human colonic cancer cells treating 
with adenosine, which disrupted the mitochondrial membrane potentials and 
activated caspase-9 and -3. The adenosine effect was inhibited by DMPX, an 
inhibitor of A2a adenosine receptors and SQ22536, an inhibitor of adenylate cyclase, 
but the apoptotic cell death was not affected by the A 1, A2b and A3 inhibitors. 
Caco-2 cell death was also induced by overexpressing A2a adenosine receptors. 
These suggested apoptosis in Caco-2 cells was via A2a adenosine receptors signaling 
13 
pathway. In addition, the possibility for an intrinsic pathway linked to adenosine 
uptake into cells and the ensuing conversion to AMP was ruled out, since adenosine 
induced apoptosis was not inhibited by an adenosine transporter or adenosine kinase 
inhibitors (Yasuda, et al., 2009). 
In short, the cytotoxic effect of adenosine might be cell type specific and a more 
relevant investigation was carried out in human HepG2 cells. Adenosine significantly 
reduced HepG2 cells viability related to the induction of cell apoptosis. Four 
adenosine receptor (A1, A2a, A3 and nonspecific receptor) antagonists (8-cpt, 
DMPX, MRS 1191, and theophylline) had no effect on cell apoptosis. However, an 
adenosine transporter inhibitor (dipyridamole) significantly attenuated apoptosis and 
caspase-3 activity. The mitochondrial membrane potential and the activity of 
caspase-8 or -9 remained unchanged in adenosine treatment. Those results suggested 
that adenosine-induced apoptosis in HepG2 cells was related to intracellular events 
rather than cell surface receptors, and caspase-3 cascade activation was required, 
which was not mediated via the mitochondrial pathway (Wu, et al., 2006). 
1.2.4. Fatty acids and sterols 
Ten free fatty acids namely lauric acid, myristic acid, pentadecanoic acid, palmitoleic 
acid, palmitic acid, linoleic acid, oleic acid, stearic acid, docosanoic acid and 
lignoceric acid and four free sterols including ergosterol, cholesterol, campesterol 
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and beta-sitosterol have recently been identified in natural Cordyceps sinensis using 
pressurized liquid extraction (PLE), trimethylsilyl (TMS) derivatization and GC-MS 
analysis (Yang, et al., 2005). Sitosterol , 5 a ,8 a -epidioxy-22E- ergosta-6,22-dien-3 
/3 -ol, 5 a ,8 a -epidioxy-22E-ergosta-6,9,22-trien-3 (3 -ol, 5 a ,6-epoxy-5 a -ergosta 
-7 ,22-dien-3 (3 -ol , and ergosterol were isolated from the ethyl acetate fraction. They 
showed cytotoxic effects on promyelocytic leukemia HL-60 cells while those with a 
peroxide ring or an epoxide ring performed better (Matsuda, et al., 2009). 
1.2.5. Vitamins and inorganics 
Cordyceps contains the vitamins B 1, B2, B 12, E, and K. Inorganic ingredients 
including K, N a, Ca, Mg, Fe, Cu, Mn, Zn, Pi, Se, Al, Si, Ni, Sr, Ti, Cr, Ga, V, and Zr 
were reported (Gui, et al., 1982). 
1.3. Cordyceps and their related biological activities 
1.3.1. Cordyceps militaris 
Park, et al. investigated the mechanisms of anti-proliferative effects of Cordyceps 
militaris aqueous extract in human leukemia U93 7 cells. The Cordyceps militaris 
aqueous extract could inhibit U937 cells growth, associated with morphological 
changes and apoptotic cell death, in a dose-dependent manner. In the treated-U937 
cells, there was a down-regulation of anti-apoptotic Bcl-2 expression and proteolytic 
activation of caspase-3, but the pro-apoptotic Bax expression and caspase-9 activity 
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were not affected. Furthermore, the Cordyceps extract inhibited cyclooxygenase-2 
and prostaglandin E2 accumulation. Those results indicated Cordyceps militaris 
aqueous extract had an anti-proliferative effect by regulating several growth 
regulatory gene products (Park, et a!., 2005). Another study demonstrated Cordyceps 
militaris fruiting bodies extract had a potent cytotoxic effect against human 
premyelocytic leukemia HL-60 cells proliferation, with characteristic apoptotic 
symptoms including DNA fragmentation and chromatin condensation. Also, 
caspase-3 activation and the specific proteolytic cleavage of poly (ADP-ribose) 
polymerase were detected (Lee, et a!., 2006). 
Recently, exposure to Cordyceps militaris extract induced apoptosis in human breast 
cancer MDA-MB-231 cells, as demonstrated by nuclear morphological change and a 
flow cytometric analysis. The extract increased hyperpolarization of mitochondrial 
membrane potential and promoted caspases activation. Conversely, those cytotoxic 
effect and apoptotic characteristics were significantly inhibited by z-DEVD-fmk, a 
caspase-3 inhibitor, which demonstrated the important role of caspase-3 in the 
observed cytotoxic effect. Besides, pretreatment with LY294002, a PI3K/ Akt 
inhibitor, significantly increased apoptosis in the Cordyceps extract-treated cancer 
cells. It suggested the correlation of mitochondria dysfunctions with the inactivation 
of Akt (Jin, et al., 2008). Similarly, the growth inhibition and apoptosis induction by 
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Cordyceps treatment in human lung carcinoma A549 cells were associated with the 
induction of Fas, catalytic activation of caspase-8, and Bid cleavage. Activation of 
caspases, down-regulation of anti-apoptotic Bcl-2 expression, and upregulation of 
pro-apoptotic Bax protein were also observed. However, such effects were 
significantly inhibited by a caspase-3 inhibitor z-DEVD-frnk. In addition, Cordyceps 
militaris extract exerted a dose-dependent inhibition on telomerase activity via 
down-regulation of human tel om erase reverse transcriptase (hTERT), c-myc and Sp 1 
expression. In short, apoptotic induction of A549 cells was going through the 
signaling cascade of death receptor-mediated extrinsic and mitochondria-mediated 
intrinsic caspase pathways. It might be mediated with diminished telomerase activity 
through the inhibition ofhTERT transcriptional activity (Park, et al., 2009). 
Concerning angiogenesis, Cordyceps militaris extract suppressed angiogenic gene 
MMP-2 expression and capillary tube formation using human umbilical vein 
endothelial cells HTl 080 (Yoo, et al., 2004). 
1.3.2. Cordyceps sinensis 
Nakamura, et al. investigated the effect of the water extract of Cordyceps sinensis on 
liver metastasis in C57BL/6 mice inoculated with Lewis lung carcinoma (LLC) and 
B 16 melanoma (B 16) cells. Mice were daily administered with water extract of 
Cordyceps sinensis (WECS). After the mice were sacrificed, it was found that WECS 
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had no significant change in the primary tumor weight in LLC-/ B 16-inoculated mice. 
The increase in relative liver weight of the tumor-inoculated mice as compared to 
normal mice reflected tumor metastasis, and this was verified by the hematoxylin-
eosin stain histopathological study showing more metastasis foci in tumor-inoculated 
mice liver. Opposing to liver metastasis, WECS-administrated mice showed a 
significant decrease in the relative liver weight compared to that of the control LLC-/ 
B 16-inoculated mice. Also, WECS showed direct cytotoxicity against LLC and B 16 
cells in vitro, but cordycepin was not cytotoxic against these cells. These findings 
suggest that WECS has an anti-metastatic activity that is probably due to components 
other than cordycepin (Nakamura, et al., 1999). In addition, anti-tumor effects of 
WECS was investigated, that WECS induced of B 16 cells apoptosis after 48 h 
exposure in vitro as determined by both the TUNEL (TdT-mediated dUTP-biotin 
nick end labeling) method and the detection of a DNA ladder. In vivo, combined 
treatment with WECS and methotrexate (MTX) in mice intravenously inoculated 
with B 16 cells was conducted. The mean survival time of mice given such 
combination of MTX and WECS was significantly longer than that in the control. 
WECS might be beneficial in the prevention of tumor metastasis as an adjuvant agent 
in cancer chemotherapy (Nakamura, et al., 2003). 
Cordyceps sinensis mycelium extract treatment at 25 Jlg/ml induced nuclear 
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fragmentation and DNA degradation, two hallmark events of apoptosis, in HL-60 
cells. The signaling pathways involved the loss of mitochondrial transmembrane 
potential, release of cytochrome c into the cytoplasm, decrease in Bcl-2 protein level, 
translocation of Bax protein from cytoplasm into mitochondria, and activation of 
caspase-2, -3, and -9. However, the initiator caspase-8 in the death receptor pathway 
was not activated. These results suggested that the extract induced apoptosis 1n 
HL-60 cells through the mitochondrial pathway rather than the death receptor 
pathway (Zhang, et al., 2007). Still concerning the anti-tumor effect, Cordyceps 
sinensis extract induced MA-l 0 mouse Leydig tumor cells apoptosis, with 
condensation of DNA chromatin and apoptotic nuclear fragmentation. Molecular 
mechanism, verified by Western blot, indicated the activation of caspase-8 dependent 
pathway and suppression ofNF-KB pathway (Yang, et al., 2006). 
However, cytotoxic effect of Cordyceps sinensis was not one-sided. Various fractions 
of extract from fruiting bodies of Cordyceps sinensis inhibited the blastogenesis, 
natural killer (NK) cell activity, and phytohemagglutinin (PHA) stimulated 
interleukin-2 (IL-2) and tumor necrosis factor-alpha (TNF-alpha) production on 
human mononuclear cells (HMNC). They were not cytotoxic on HMNC and they 
acted as immunosuppressive ingredients which suggested the protection from 
over-reaction in inflammation (Kuo, et al., 1996). Studying the healing properties of 
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Cordyceps sinensis, it was discovered that it has renoprotective effects mediated by 
inhibiting the expression of inflammatory chemokine MCP-1 and cytokine TNF-a. 
Also, it reduced Fas/FasL involved in the TNFR1 receptor apoptotic cascade, and the 
treatment had no effect on Bcl2/Bax expression taking part in the mitochondria 
apoptosis. Caspase-3 activity in the Ischemia/ reperfusion rats' kidney was 
significantly reduced after receiving Cordyceps extract treatment (Shahed, et al., 
2001). 
It has been reported that Cordyceps sinensis could scavenge reactive oxygen species 
peroxynitrite (ONOO-), a hydroxyl radicals generated by SIN-1. ONOO- oxidized the 
deoxyribose to produce malondialdehyde and Cordyceps sinensis possessed a potent 
antioxidant activity by reducing malondialdehyde production. Cordyceps sinensis 
also showed a marked inhibitory effect on lipid peroxidation in LDL mediated by 
macrophages and copper, and subsequent accumulation of cholesteryl ester in 
macrophages. Such radical scavenging and antioxidant functions suggested the 
anti-apoptotic activity of Cordyceps sinensis (Yamaguchi, et al., 2000). 
LDL promoted proliferation of cultured human glomerular mesangial cells, which 
accelerated vascular and glomerular injury. Conversely, Cordyceps sinensis inhibited 
glomerular mesangial cells proliferation induced by LDL, such that Cordyceps 
sinensis played a protective role in renal disease (Wu, et al., 2000). Moreover, 
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Cordyceps sinensis could stimulate steroidgensis in MA -1 0 mouse Leydig tumor 
cells via activating both phosphokinase A and phosphokinase C signal transduction 
pathway (Chen, et al., 2005). It was also supported by in vivo study that Cordyceps 
sinensis fractions could stimulate testosterone production (Huang, et al., 2004). 
1.4. Proteomic tools used to study the change in protein expression 
profiles 
1.4.1. Proteomic tools in studies of the change in protein expression 
Fueled by a wealth of genome sequencing information, proteomics has become one 
of the most important disciplines for characterizing gene function, for building 
functional linkages between protein molecules, and for providing insight into the 
mechanisms of biological processes in a high-throughput mode. Proteomics focused 
on protein identification, localization, expression, interactions and modifications. 
Therefore, several arbitrary areas emphasizing the recent technologies development 
and applications emerged, which were spectrometry-based proteomics, 
proteome-wide biochemical assays, systematic structural biology and imaging 
techniques, proteome informatics, and clinical applications. Biologically useful 
insights into protein function often required a combination of different proteomic 
approaches (Tyers, et al., 2003). Among those diverse technologies, initial 
proteomics efforts relied on protein separation by two-dimensional gel 
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electrophoresis with subsequent mass spectrometric identification of protein spots, 
and they would be further elaborated (Blackstock, et al., 1999). 
1.4.2. Two-dimensional gel electrophoresis 
Early in 1970s, O'Farrell demonstrated the possibility to separate proteins based on 
their isoelectric points and molecular weights by electrophoresis on polyacrylamide 
gels. Two-dimensional gel electrophoresis (2D gel electrophoresis) has remained 
unchallenged as an efficient way for separating complex protein mixtures and was 
highly reproducible (O'Farrell, et al., 1975). Large-format gels and refined pi range 
improved the resolving power and resolution. Coomassie blue or silver staining has 
allowed visualization thousands of proteins and protein quantitation, while modem 
fluorescent dyes added highly accurate quantitative dimension (Marouga, et a!., 2005; 
Timms, et a!., 2008). Protein extraction and solubilization were critical steps for 2D 
gel electrophoresis, but hydrophobic proteins tended to precipitate during IEF 
(Santoni, et a!., 2000). Researches are kept enhancing the compatibility of 2D gel 
electrophoresis with high hydrophobic and high basic or acidic proteins. 
1.4.3. Mass spectrometry 
Mass spectrometry was carried out in the gas phase on ionized analytes. A mass 
spectrometer consisted of an ion source, a mass analyzer that measured the 
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mass-to-charge ratio (m/z) of the ionized analytes, and a detector. Electrospray 
ionization (ESI) and matrix -assisted laser desorption and ionization (MALD I) were 
commonly used techniques to volatize and ionize the proteins or peptides 
respectively. The mass analyzer should be stringent in the parameters of sensitivity, 
mass accuracy, resolution and generation of informative mass spectra. Four types of 
mass analyzer currently used in proteomics research were the ion trap, quadrupole, 
time-of-flight (ToF) and Fourier transform ion cyclotron (FT-MS) analyzers 
(Aebersold, et al., 2003). The molecular weight of a protein was hardly used for 
discrimination, so protein identification relied on trypsin proteolysis followed with 
analysis of digested pep tides of the purified protein. MALDI-ToF mass spectrometry 
has been usually used for peptide mass fingerprinting (PMF) which was searched 
against a computer-generated protein digestion database (Blackstock, et al., 1999). It 
was suggested that several major challenges need to be resolved, which included the 
lack of analytical post-translational modification technology, limited sensitivity, low 
resolution at high mass to charge region and long analysis time, in order to make 
tremendous progress in the future (Chen, et al., 2008). 
1.4.4. Current challenges 
Despite maJor advances 1n developing proteomic technologies, vanous 
methodological challenges are still encountered. The difficulty of sample complexity 
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affects the depth of coverage of proteome. Dynamic concentration range of proteins 
in a given sample makes proteomic approaches focusing on the abundant proteins, 
which mask the proteins with lower copy numbers. A variety of separation 
techniques reduce sample complexity based on the proteins physical and chemical 
properties. However, such additional steps may lead to random loss of proteins 
species, increase proteolysis and alter post-translational modifications. In addition, 
gene expression level affected by microRNA and epigenetic factors, protein isoforms 
due to differential splicing of gene transcripts and diverse post-translational 
modifications cause the characterization of proteomes extremely challenging. There 
are also technical and instrumental limitations, so conventional methods have been 




2.1. Cultivation of Cordyceps militaris 
Cordyceps militaris was cultivated on the rabbit food medium (25g rabbit food, 15g 
agar with 4o/o w/v sucrose and 1% w/v yeast extract in IL Milli-Q water) (Millipore). 
The preparation was as follows: Rabbit food in Milli-Q water was heated until just 
boiled in a microwave oven. The debris was then filtered out with 3 piles of 
cheesecloth. Yeast extract (Bacto ), sucrose (USB) and agar (Bacto) were added into 
the filtrate and then the whole mixture was sterilized by autoclave for 15 minutes. 
About 75ml sterilized medium was added to a 75cm2 cell culture flask (BD Falcon). 
Cordyceps militaris mycelia were inoculated onto the solidified rabbit food agar in 
flowhood. The cultures were allowed to grow at room temperature for 1 month and 
the mycelia could be collected. 
Around 2 months after inoculation, fruiting body of Cordyceps militaris began to 
merge from some small knobs on masses of mycelia. Starting from that time, the 
fruiting body was allowed to grow for another one month. It would grow bigger in 
size which was ready for harvesting. 
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2.2. Preparation of Cordyceps extracts for anti-proliferation assay 
on cell lines 
2.2.1. Types of the extracts of Cordyceps 
Four types of water extracts of Cordyceps were prepared: 1) cultivated Cordyceps 
militaris fruiting body extract (CMFB); 2) cultivated Cordyceps militaris mycelia 
extract (CMM); 3) wild Cordyceps sinensis fruiting body extract (CSFB) and 4) wild 
Cordyceps sinensis mycelia extract (CSM). 
2.2.2. Preparation of the Cordyceps extracts 
The mycelia and fruiting body of both cultivated Cordyceps militaris and wild 
Cordyceps sinensis collected were ground with pestle and mortar in presence of 
liquid nitrogen. Milli-Q water was added to the ground samples and they were 
sonicated for 15 minutes. Then all portions were centrifuged and the supernatants 
were filtered with 0.45~m pore size filter to remove the debris. The filtered extracts 
were taken for lyophilization. The dry powder of four different types of extracts were 
collected and stored in the desiccators for further usage. 
2.3. Anti-proliferation assay on cell lines for extract screening 
2.3.1. Cell lines and culturing condition 
The cell lines i) Human foreskin fibroblast (Hs68), ii) Human hepatocellular 
carcinoma (HepG2), iii) Human mucoepidermoid pulmonary carcinoma (H292) and 
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iv) Mouse neuroblast (Neuro2a) were used in this study. They all were adhesive cell 
lines and were purchased from American Type Culture Collection (ATCC). 
For Hs68, H292 and Neuro2a, they were cultured in DMEM medium (Invitrogen 
Life Technologies) supplemented with 10% v/v fetal bovine serum (FBS; Thermo 
Fisher Scientific), 44mM sodium bicarbonate (Invitrogen Life Technologies), and 
1% v/v liquid penicillin-streptomycin (10,000U penicillin (base) and 10,000 11g 
streptomycin (base )/ml) (Invitrogen Life Technologies). The cell lines were kept in 
the humidified incubator supplied with 5% C02 at 3 7°C. 
For HepG2, it was cultured in RPMI 1640 medium (Invitrogen Life Technologies) 
supplemented with 10% v/v fetal bovine serum (FBS; Thermo Fisher Scientific), 
24mM sodium bicarbonate (Invitrogen Life Technologies), and 1% v/v liquid 
penicillin-streptomycin (1 O,OOOU penicillin (base) and I 0,000 11g streptomycin 
(base )/ml; Invitrogen Life Technologies). The cell line was kept in the humidified 
incubator supplied with 5o/o C02 at 37°C. 
2.3.2. Viable cell count using trypan blue exclusion method 
When cells grew to confluence, the medium inside the culture flask was discarded, 
and the cells was washed with IX phosphate buffer saline (IX PBS) (Invitrogen Life 
Technologies) twice. Then 2ml 0.05% trypsin-EDTA (Invitrogen Life Technologies) 
was added to perform trypsinization in order to detach the cells from the flask. The 
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activity oftrypsin-EDTA was terminated by adding 3ml medium as medium contains 
FBS which contains trypsin inhibitor. The cells were transferred to a 50ml centrifuge 
tube and centrifuged at 11 OOrpm (Eppendorf centrifuge 581 OR) for 5 minutes. The 
supernatant was discarded and the pellet was resuspended in 5ml medium by 
vortexing. Viable cell count was performed using the trypan blue exclusion method 
at each passage to ensure the cells were in exponential phase throughout the 
experiment (Baatout, et al., 2004). Equal volume of cell suspension and 20 mg/ml 
trypan blue dye (Sigma) were mixed well. The trypan blue exclusion method is a 
negative staining method: the viable cells appear transparent in the dye, while the 
dead cells were stained as they lose their membrane integrity and they will absorb the 
dye. Viable cell density was found out using the Hausser Bright-line counter (a 
haemocytometer of 0.1mm depth; Hausser Scientific). The cell density can than be 
calculated by the following equation: 
Cell density ( cells/ml) = cell number x 1/0.2 x 1000 x 2 
2.3.3. Anti-proliferation assay on cell lines using MTT assay 
Similar procedures were performed as mentioned in viable cell count using trypan 
blue exclusion method (section 2.3 .2). The cells were diluted with medium in order 
to obtain the optimal plating density of 1 x 104 cells/mi. 1 OOf.!l/well of corresponding 
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cells suspension were seeded in 96-well microtiter plates (BD Falcon) and incubated 
in incubator, with 5% C02, at 3 7 °C for 24 hrs to allow cell attachment. After 
incubation, the lyophilized water extracts of different concentrations were dissolved 
in the medium directly, filtered with a filter of 0.22J.Lm pore size and added to the 
cells (1 OOJ.Lllwell). Each concentration was added to the plates in 10 replicates. 
Control wells were the corresponding cells added with medium but without any 
extract. 16 wells were left blank for the background absorbance during the OD 
measurement. The plates were incubated for 48 hrs. At the end of each incubation 
period, the plates were centrifuged at 2500rpm (Eppendorf centrifuge 581 OR) for 5 
minutes. After pouring away the medium, the residual medium was removed by 
inverting the plates and centrifuged at 300rpm for 1 minute. Then, 30J.!l 3-( 4, 
5-Dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT; Sigma) dissolved 
in 1X PBS at 5 mg/ml was added to each well. The plates were incubated at 37 °C for 
2 hours. Afterwards, the MTT solution was removed by the same mean as removing 
the medium. Viable cells would then be stained as blue precipitant. The color was 
developed and eluted with 1 OOJ.!l dimethyl sulfoxide (DMSO; Sigma) per well. The 
plate contents were automixed for 10 seconds and the absorbance was taken at 
570nm using a microplate spectrophotometer (SpectraMax 250; Molecular Devices) 
(Varvaresou, et al., 2004). 
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2.3.4. Determination of the IC50 values 
Percentage of inhibition was calculated using the following formula: 
Average absorbance of treated cells with Cordyceps extracts- average background absorbance 
Average absorbance of control cells with medium only- average background absorbance 
xlOO% 
The percentage of control cells in each well treated with culture medium only was 
considered as 100%, such that there was no inhibition. IC50 (the inhibitory 
concentration, 50%) acts as a parameter for the measures of the effective 
concentrations at which 50% of cell density were inhibited after treating with 
different Cordyceps water extracts (Varvaresou, et al., 2004). 
From the anti-proliferation assay in HepG2 and Hs68 cell lines, the Cordyceps water 
extracts with lower IC50 values were selected for further investigation. 
2.3.5. Statistical Analysis 
Data was presented as mean ± SD with Microsoft Excel made statistical analyses. 
Multiple comparisons between variances were done with Bonferroni test (ANOVA) 
using SPSS software, and those differences with p< 0.01 were considered statistically 
significant. 
2.4. Proteomic studies for HepG2 and Hs68 after the treatment of 
extracts 
2.4.1. Protein sample preparation of HepG2and Hs68 
Larger scale of each of the cell batches grew in 6-well tissue culture plate from the 
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anti-proliferation assay was obtained. In detail, 2ml of diluted cells suspension with 
an optimal plating density of 1 x 104 cells/ml were seeded into each well of the 6-well 
tissue culture plates (BD Falcon). They were incubated in incubator supplied with 
5o/o C02, at 37 °C for 24 hrs to allow cell attachment. After incubation, those control 
cells received an addition of 2ml/well medium. Each well of the treatment cells 
received 2ml of Cordyceps extract dissolved in appropriate medium such that the 
final concentration reached the corresponding IC50 value. The plates were incubated 
for 48 hrs. After incubation, the medium was removed and the cells were washed 
twice with 2ml IX PBS. For each well of the 6-well plate, 20f.ll rehydration stock 
solution (8M urea, 2% w/v CHAPS, 0.002% w/v bromophenol blue) was added and 
cell scraper was used to lift the cells from the plate. Cells of same type were pulled 
together, and they are lysed by mechanical mean of freeze-and-thaw. Centrifugation 
of the cell lysate in 15000rpm (Hitachi CT15RE) for 5 minutes at 4 °C, the 
supernatant obtained was centrifuged again at the same condition to further remove 
the cell debits. After that, the supernatant was collected in a new 1.5ml 
microcentrifuge tube and stored at -80 °C before use. 
2.4.2. Protein quantitation 
Each protein concentration was measured using PlusOne 2-D Quant Kit (GE 
Health care). A standard curve was prepared for every quantitation using the 2 mg/ml 
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bovine serum albumin (BSA) standard solution provided in the kit. The essay range 
was 0.5-50f.lg. 500f.ll precipitant solution was added in each protein sample tube, 
including the standard curve tubes. After 2-3 minutes incubation, 500f.ll 
co-precipitant solution was added into each tube, with mixing by inversion. Then, all 
the tubes were centrifuged at 1 OOOOg for 5 minutes. Small protein precipitates should 
then be visible, and the supernatant was discarded rapidly in order to avoid 
resuspension. The tubes were repositioned in the centrifuge with the cap-hinge and 
the pellet locating outward. The tubes were then centrifuged briefly again so as to 
bring the remaining fluid to the bottom. The remaining supernatant could be 
completely removed. Then, 1 OOf.ll copper solution and 400f.ll distilled water was 
added into each tube allowing protein precipitates totally dissolved. 1ml of working 
reagent, which was prepared by mixing 100 parts of color reagent A with 1 part of 
color reagent B, was added to each tube. The tubes were mixed by inversion and 
incubated at room temperature for 15-20 minutes. Finally, the absorbance at 480nm 
of all the tubes including the standard curve tubes was measured using distilled water 
as blank. A standard curve of the absorbance of standards against the protein quantity 
was plotted and the protein concentration of the samples can be determined from 
their absorbance using the standard curve. 
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2.4.3. 2D Gel electrophoresis 
Isoelectric focusing (IEF) was performed ustng Ettan IPGphor III isoelectric 
focusing system (GE Healthcare). The samples was quantified by PlusOne 2-D 
Quant Kit as mentioned in the protein quantitation section and normalized to 80J..tg. 
Rehydration stock solution and 2% v/v Pharmalyte (GE Healthcare) of 
corresponding pH range were added to bring up to a volume of 125 f.ll. The prepared 
samples were applied to the 7cm Immoboline DryStrip gels (pH3-10 linear) by 
rehydration loading overnight. The first dimension IEF was performed at 1 OOOOVhr. 
Before performing the second dimension, the IPG strip was equilibrated at room 
temperature for 15 minutes in the SDS equilibration buffer (50mM Tris-HCl pH8.8, 
6M urea, 30o/o v/v glycerol, 2% w/v SDS and 0.002% bromophenol blue) with 
addition of 2.5o/o w/v dithiothreitol (DTT) prior to the usage. The strip was then 
washed with Milli-Q water briefly and further equilibrated at room temperature for 
another 15 minutes in the SDS equilibration buffer containing 50mM Tris-HCl pH8.8, 
6M urea, 30% v/v glycerol, 2o/o w/v SDS, 0.002% bromophenol blue and 2.5% w/v 
iodoacetamide. 
The strip was rinsed with Milli-Q water briefly and put on top of the 4% stacking gel 
and 12% separating gel inside the gel cassette with lmm thickness. The strip was 
covered with 400f.ll agarose sealing solution (0.5% agarose and 0.002% w/v 
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bromophenol blue in SDS electrophoresis buffer). The agarose sealing solution was 
allowed to polymerize. The gel cassettes and the SDS electrophoresis buffer (25mM 
Tris-base, 192mM glycine and 0.1% w/v SDS) mentioned above was assembled 
inside the electrophoresis systems (Invitrogen XCell Surelock mini-vertical 
electrophoresis systems, two gels per unit) and run at 80V for 30 minutes and then 
180V for 1.5 hours. 
After the second dimension SDS-PAGE run, the gel were washed with Milli-Q water 
and then stained with 50ml Coomassie staining solution ( 45% v/v methanol, 10% v/v 
acetic acid, 0.15% w/v Coomassie Brilliant Blue R250) for at least 20 minutes. The 
gels will be finally destained overnight using 50ml destaining solution ( 45% v/v 
methanol, 10% v/v acetic acid in Milli-Q water) (Decker, eta!., 2003). 
2.4.4. Image analysis 
After proper staining and destaining, the background of the gels was fade away 
leaving the protein spots and then the gels were scanned under visible light at 300dpi 
using ImageS canner (Amersham Biosciences ). Analysis was carried out using the 
computer program, ImageMaster 2D Platinum 5.0 (Amersham Biosciences). Spots 
were detected automatically while manual spot editing and deleting was performed if 
necessary. Distinct spots were selected as landmark for gel alignment and spots 
matching after mass spectrometry analysis. Duplicated gels were studied for each 
34 
sample, and the gels with the protein spots from the untreated cell line were used as 
the reference gels. 
2.4.5. In gel digestion and MALDI-ToF MS 
All spots from the gels were excised after image analysis. The spots transferred to 
1.5ml microcentrifuge tubes were destained with 50mM ammonium bicarbonate, 
dehydrated with ACN and then dried completely inside a SpeedVac (LABCONCO). 
5J.!l of 50mM ammonium bicarbonate containing 20ng/J.!l Sequencing Grade 
modified trypsin (Prom ega) was added to the dried gel spots for rehydration and 
protein digestion. The samples were incubated overnight at 37°C. Afterwards, 5J.!l 
extraction buffer (60% ACN, 2.5% TFA) was added to the samples, followed by 
sonication for 10 minutes. Mass-spec plate was spotted twice with 0.4J.!l digested 
sample solution, and finally 0.4J.!l matrix (x-cyano-4-hydroxycinnamic acid) was 
spotted. Mass spectrometry was performed using the 4 700 proteomics analyzer 
(Applied Biosystems ). The mass tolerance of 0.5 atomic mass unit was set in all 
searches. Oxidation of methionine was taken into account for the modification. The 
peptide mass fingerprint data collected was then searched against the NCBI database 
with the all taxonomy selection. The proteins with CI% larger than 95 was classified 
as confirmed match. 
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2.5. Cell cycle analysis 
2.5.1. Cell samples preparation 
2ml of diluted cells (HepG2, Hs68 and H292) suspension with an optimal plating 
density of 1 x 104 cells/ml were seeded into each well of the 6-well tissue culture 
plates (BD Falcon). They were incubated in incubator supplied with 5% C02, at 37 
°C for 24 hrs to allow cell attachment. After incubation, those control cells received 
an addition of 2mllwell medium. Each well of the treatment cells received 2ml of 
Cordyceps extract dissolved in appropriate medium such that the final concentration 
reached the corresponding IC50 value. The plates were incubated for 48 hrs. After 
incubation, the solution inside the wells was discarded and the cells were washed 
with 2ml IX PBS twice. Then 200J.tl 0.05% trypsin-EDTA was added to perform 
trypsinization to allow the cells dissociated from the tissue culture plates and the 
activity of trypsin-EDTA was attenuated by adding 300J.tl medium. The cells 
receiving the same the treatment could be grouped together and transferred to 1.5ml 
microcentrifuge tubes (Axygen Scientific). 
2.5.2. Popidium iodide staining 
Cell pellets retrieved after centrifugation at 5000rpm (Hitachi CT15RE) for 3 
minutes were resuspended in lmllX PBS for washing. The cells were then collected 
by centrifugation in the same mean and then 300J.tl IX PBS was quickly added into 
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the tubes with gentle vortexing to avoid clumping. 700f.ll absolute ethanol was added 
for cells fixation and the cells were fixed at 4 °C for 1 hour. The 70% ethanol was 
removed by discarding the supernatant after centrifugation and the fixed cells were 
washed with lml IX PBS. The cells retrieved after centrifugation were incubated 
with lml popidium iodide staining solution (PI stain; 2% w/v popidium iodide, 1% 
w/v DNase free RNase, 0.1% v/v Triton X-1 00, 0.1% v/v Nonidet P40, 150mM NaCl, 
lOOmM Tris, pH7.4) in dark for 1 hour. 
2.5.3. Flow cytometry 
The PI-stained cells were poured into the flow tube and analyzed by flow cytometry 
using Cytomics FC500 system (Beckman Coulter). 488nm laser beam was used for 
excitation, and the residual debris was real time gating out using the forward scatter 
signal. The red fluorescence resulting from the laser excitation of the dye-DNA 
complex in each cell was collected and quantified through a system of filters and 
photomultipliers. Data of 1 x 105 cells was recruited in the DNA per cell frequency 
distribution histogram, such that the abscissa represented linear scale of DNA 
content while the height of the bars indicated the number of cells recorded. The 
histograms were analyzed using the Multicycle A V software (Phoenix Flow 
Systems). With its well-established mathematical model, the histograms were fitted 
and the percentage of each growth phase was generated. Experiments were repeated 
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for three times for each sample. 
2.5.4. Statistical Analysis 
Data was presented as mean ± SD with Microsoft Excel made statistical analyses. 
Multiple comparisons between variances were done with Bonferroni test (ANOVA) 
using SPSS software, and those differences with p< 0.01 were considered statistically 
significant. 
2.6. Western blotting 
2.6.1. Protein sample preparation ofHepG2 and Hs68 
Protein samples were prepared as mentioned in proteomic study (section 2.4.1). The 
protein samples harvested from the cells were used within one week for western 
blotting. 
2.6.2. SDS-PAGE 
A 1 O-w ell polyacrylamide gel containing 4% stacking gel and 15% separating gel 
with 1mm gel thickness was cast. 40Jlg protein per sample in sample loading buffer 
was boiled at 99 °C for 5 minutes and loaded into each well for analysis. 5 Jll of 
Kaleidoscope Precision Plus Protein Standard (Bio-Rad Laboratories) was used for 
each gel. The gels and the SDS electrophoresis buffer mentioned above were put 
inside the electrophoresis systems (Invitrogen XCell Surelock mini-vertical 
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electrophoresis systems, two gels per unit) and run with 80V for 30 minutes and then 
170V for 1.5 hours. 
2.6.3. Protein Transblotting 
After running, the gel was rinsed with Milli-Q water, and sandwiched inside the 
iBlot™ Dry Blotting System (Invitrogen) together with iBlot Anode Stack (include 
the PVDF membrane, 0.2f.lm, low fluorescence), filter paper and the iBlot™ Cathode 
Stack. Any trapped air bubble that interfered with efficient protein transfer was 
removed using the de-bubbling roller. According to manufacturer instruction, pre-set 
protocol P3 was used in order to perform the transblotting in 7 minutes. 
2.6.4. Membrane Blocking and Antibody Incubations 
In order to investigate if the cells have undergone the caspase-dependent apoptosis 
after treatment, western blotting against actin, procaspase-3, cleaved caspase-3, 
procaspase-7, cleaved caspase-7, procaspase-9 and cleaved caspase-9 (Cell signaling 
technology) were performed. If the cells have undergone the caspase-dependent 
apoptosis, their inactivated form procaspases would be cleaved into the activated 
form of effective caspases. Immunoblotting for actin was performed as the control. 
The PVDF membrane with the electrophoretic transferred proteins was incubated in 
25ml blocking buffer (5% w/v nonfat powdered milk in TBS containing 2mM 
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Tri-HCl and 15mM NaCl, pH7.5) for 1 hour at room temperature with gentle 
agitation. Then, the membrane was washed three times for 5 minutes in 15ml TBST 
(2rnM Tri-HCl, 15rnM NaCl and 0.1% Tween-20, pH7.5). The membrane was then 
incubated with primary antibody (1: 1 000) (Cell signaling technology) in 4ml TBST 
with gentle agitation overnight at 4 °C. After that, the membrane was washed three 
times of 5 minutes with 15ml TBST. Horseradish peroxidase HRP-conjugated 
secondary antibody (1 :2000) (Cell signaling technology) in 4ml TBST was then 
added. Gentle agitation for 1 hour at room temperature allowed the secondary 
antibody recognizing the primary antibody for detection. The membrane was washed 
again for three times of 5 minutes with 15ml TBST before chemiluminescent 
detection. 
2.6.5. Detection of Proteins 
lml substrate LumiGLO® (50f.ll 20X LumiGLO® and 50f.ll 20X peroxide in 900f.ll 
Milli-Q water) was added covering the membrane with incubation at room 
temperature for 1 minute. The membrane was then wrapped in plastic wrap. 




3.1. Investigation of anti-proliferating effect of Cordyceps extracts 
on HepG2 and Hs68 using MTT assays 
3.1.1. Cordyceps militaris fruiting body extract- CMFB 
The anti-proliferation effect of Cordyceps militaris fruiting body extract on the 
human cancer cell line HepG2 and the normal cell line Hs68 were shown in Fig. 
3 .1.1 a and 3 .1.1 b. The data indicated that Cordyceps militaris fruiting body extract 
exhibited an anti-proliferating activity in a dose-dependent manner on HepG2. The 
results of IC50 values revealed Cordyceps militaris fruiting body extract possessed 
significant inhibition with p<0.01 on HepG2 at very low concentration (IC50 value= 
0.0085 mg/ml), while a low cytotoxic effect was found in Hs68 (IC50 value = 0.052 
mg/ml). The anti-proliferation effect on HepG2 was much stronger than that in 
Hs68. 
3.1.2. Cordyceps militaris mycelia extract- CMM 
The anti-proliferation effect of Cordyceps militaris mycelia extract on the cancer 
cell line HepG2 and the normal cell Hs68 was shown in Fig. 3 .1.2a and 3 .1.2b. The 
data indicated that Cordyceps militaris mycelia extract exhibited an 
anti-proliferating activity on HepG2 in a dose-dependent manner. The result of ICso 
value revealed Cordyceps militaris mycelia extract possessed significant inhibition 
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with p<O.Ol on HepG2 at low concentration (IC50 value= 0.035 mg/ml), but the ICso 
value cannot be determined in Hs68. Although there was a certain degree of 
cytotoxicity, the inhibitory effect tended to level off at around 44% upon the increase 
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Fig. 3 .1.2b Effect of Cordyceps militaris mycelia extract on Hs68 
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3.1.3. Cordyceps sinensis fruiting body extract- CSFB 
The anti-proliferation effect of Cordyceps sinensis fruiting body extract on the 
cancer cell line HepG2 and the normal cell line Hs68 were shown in Fig. 3 .1.3a and 
3 .1.3b. The graph indicated that Cordyceps sinensis fruiting body extract exhibited 
an inhibitory effect on cancer cell line HepG2 in a dose-dependent manner. From the 
result of ICso value, Cordyceps sinensis fruiting body extract was only effective at 
high concentrations on HepG2 (IC50 values = 1.85 mg/ml), and its inhibition was 
significant with p<O.Ol when concentration was greater than 0.5 mg/ml. However, 
there was no significant inhibition displayed in Hs68 and no IC50 value for 
Cordyceps sinensis mycelia extract could be found. 
3.1.4. Cordyceps sinensis mycelia extract - CSM 
The anti-proliferation effect of Cordyceps sinensis mycelia extract on the cancer cell 
line HepG2 and the normal cell line Hs68 were shown in Fig. 3 .1.4a and 3 .1.4b. 
Cordyceps sinensis mycelia extract only possessed significant inhibition with p<O.Ol 
at high concentrations (>4 mg/ml) on HepG2 and the ICso value cannot be 
determined in the range of tested concentrations. At some lower dosages ( <3 mg/ml), 
the Cordyceps extract had no cytotoxicity and even showed significant negative 
inhibitory effect on HepG2. Similar trend was displayed in Hs68 cell line, and again, 
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ICso value could not be found. These indicated that Cordyceps sinensis IS not 
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Fig. 3 .1.4b Effect of Cordyceps sinensis mycelia extract on Hs68 
#data has sig. level P>0.05 using AN OVA, which indicates no significant inhibition 
is observed when compared with control concentration 
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3.1.5. Comparison of the anti-proliferation effects of the Cordyceps extracts 
CMFB, CMM, CSFB and CSM 
The results of MTT assays were summarized in the Fig. 3.1.5a. Comparing the ICso 
values of the Cordyceps extracts, it was found that both Cordyceps militaris fruiting 
body and mycelia extracts were capable of inhibiting the proliferation of cancer cells 
effectively when compared with Cordyceps sinensis fruiting body and mycelia 
extracts and so the pure compounds cordycepin and adenosine. Thus these two 
extracts were selected for further treatment in other cell lines. Though the Cordyceps 
militaris extracts had inhibitory effects on the growth of Hs68, the IC50 values were 
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Fig. 3.1.5a A graph showing the IC50 values of different Cordyceps extracts on 
HepG2 and Hs68 after 48 hours treatment 
Key: 11 inhibition is level-off at ----44o/o as extract concentration is 0.4-0.8 mg/ml 
# inhibition cannot reach 50% as extract concentration is 5 mg/ml 
* no significant inhibition can be observed 
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3.2. Investigation of anti-proliferating effect of Cordyceps militaris 
extracts on H292, Neuro2a and WIL2-NS using MTT assays 
3.2.1. Cordyceps militaris fruiting body extract- CMFB 
The anti-proliferation effect of on the cancer cell lines H292, Neuro2a and WIL2-NS 
was shown in Fig. 3.2.1a, 3.2.1b and 3.2.1c. The data indicated the anti-proliferating 
activity of Cordyceps militaris fruiting body extract was in a dose-dependent manner 
on H292 and Neuro2a cancer cell lines. The results of IC50 values revealed 
Cordyceps militaris fruiting body extract possessed significant inhibition with 
p<O.Ol on H292 and Neuro2a at very low concentrations (IC50 value = 0.008 and 
0.008 mg/ml respectively). However, there was no significant inhibition displayed in 
another normal cell line WIL2-NS and no IC50 value could be found. 
3.2.2. Cordyceps militaris mycelia extract - CMM 
The anti-proliferation effect of on the cancer cell lines H292, Neuro2a and WIL2-NS 
was shown in Fig. 3.2.2a, 3.2.2b and 3.2.2c. The data indicated the anti-proliferating 
activity of Cordyceps militaris mycelia extract was in a dose-dependent manner on 
H292 and N euro2a cancer cell lines. The results of IC5o values revealed Cordyceps 
militaris fruiting body extract possessed significant inhibition with p<O.Ol on H292 
and Neuro2a at very low concentrations (ICso value = 0.08 and 0.025 rng/rnl 
respectively). Again, there was no significant inhibition displayed in another normal 
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Fig. 3.2.1 b Effect of Cordyceps militaris fruiting body extract on Neuro2a 
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3.3. Changes in total protein expression profiles in cell lines 
3.3.1. Protein samples preparation 
Human hepatocellular carcinoma HepG2 cell line was treated with either Cordyceps 
militaris fruiting body extract or mycelia extract at the concentrations of their 
corresponding ICso values determined in the MTT assays. After 48 hours treatment, 
three groups of HepG2 cells under different conditions were collected for 
comparison: control HepG2- without treatment; CMFB-treated HepG2 (IC50 : 0.0085 
mg/ml); CMM-treated HepG2 (IC50 : 0.035 mg/ml). 
Human foreskin fibroblast Hs68 cell line was used as the control to determine 
whether Cordyceps militaris fruiting body or mycelia extract made any changes in 
normal cells at the concentrations of IC50 values. After 48 hours treatment, three 
groups of Hs68 cells under different conditions were compared: control Hs68-
without treatment; CMFB-treated Hs68 (IC5o: 0.0085 mg/ml); CMM-treated Hs68 
(ICso: 0.035 mg/ml). 
3.3.2. 2D gel electrophoresis analysis of protein from cell lines 
Protein expression differences in cell lines under normal and treatment (with either 
Cordyceps militaris fruiting body or mycelia extract) conditions were studied by 2D 
gel electrophoresis. 2D gel electrophoresis was analyzed in duplicate for each group. 
56 
In each 2D gel analysis, 80~g of proteins from the corresponding harvested cell lines 
were used were separated by pis 3-10 linear 7cm gels and by molecular masses of 
6-200kDa.Gels were compared via Image Master 5.0 (GE Healthcare). Gel image 
from untreated control cell lines was chosen as the reference gel. Comparing with 
the control, the spots (proteins or isoforms) in treatment groups with at least 
two-fold variations were marked with numbers. 
3.3.2.1. HepG2 
Fig. 3.3.2.1a, 3.3.2.1 b and 3.3.2.1c displayed three representative 2D gel images of 
proteins profiles of HepG2 cells, which included the normal untreated, 
CMFB-treated and CMM-treated groups. Around 200 spots detected in the reference 
gel were found matched with those on the other gels. 
For HepG2 cells treated with Cordyceps militaris fruiting body extract, there were 
27 spots detected with significant changes in protein expression. Within them, 17 
spots were down-regulated and 10 spots were up-regulated in comparing with the 
reference gel. 
For HepG2 cells treated with Cordyceps militaris mycelia extract, there were 20 
spots detected with significant changes in protein expression. Within them, 12 spots 
were down-regulated and 8 spots were up-regulated in comparing with the reference 
gel. The fold-differences of protein spots in treatment groups when compared with 
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the untreated control were listed in Table 3.3.2.1a. 
3.3.2.2. Hs68 
Fig. 3.3.2.2a, 3.3.2.2b and 3.3.2.2c displayed three representative 2D gel images of 
proteins profiles of Hs68 cells, which included the normal untreated, CMFB-treated 
and CMM-treated groups. Around 150 spots detected in the reference gel were 
found matched with those on the other gels. 
For Hs68 cells treated with Cordyceps militaris fruiting body extract, there were 7 
spots detected with significant changes in protein expression. Within them, 5 spots 
were down-regulated and 2 spots were up-regulated in comparing with the reference 
gel. 
For Hs68 cells treated with Cordyceps militaris mycelia extract, there were 5 spots 
detected with significant changes in protein expression. Within them, 4 spots were 
down-regulated and 1 spots were up-regulated in comparing with the reference gel. 
The fold-differences of protein spots in treatment groups when compared with the 
























































































































































































































































































































































































































































































SpotiD CMFB CMM SpotiD CMFB CMM 
Al -2.17 -2.63 B1 1.56 2.42 
A2 -2.38 -2.27 B2 18.04 12.18 
A3 -4.20 -2.50 B3 2.11 2.00 
A4 -1.61 -2.70 B4 2.06 1.68 
AS -2.04 -2.22 B5 2.73 2.72 
A6 -1.56 -2.22 B6 2.55 1.58 
A7 -1.79 -1.79 B7 1.57 1.54 
A8 -1.75 -1.54 B8 1.54 1.93 
A9 -2.44 -1.69 B9 2.11 
AlO -3.03 -2.17 B10 2.60 
All -1.79 -1.92 






Table 3.3 .2.1 a The fold-differences of proteins spots with significant expression 
changes in HepG2 cells treated with CMFB and CMM when compared with the 
control 
Treatment Treatment 
SpotiD CMFB CMM SpotiD CMFB CMM 
Al -2.04 -1.96 B1 1.52 1.51 
A2 -1.96 -1.82 B2 1.98 
A3 -2.44 -2.44 
A4 -1.72 -1.67 
AS -1.69 
Table 3.3.2.2a The fold-differences of proteins spots with significant expression 
changes in Hs68 cells treated with CMFB and CMM when compared with the 
control 
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3.3.3. Differentially expressed proteins identification 
The differentially expressed protein spots in the stained gels were excised and were 
subject to a series of steps for in-gel tryptic digestion. The extracted tryptic peptides 
were analyzed using the 4700 Proteomics Analyzer MALDI-ToF/ToF (Applied 
Biosystems) for tandem mass spectrometry. Resulting peptide mass lists were 
submitted to NCBI database interrogation. Table 3.3.3.1a, 3.3.3.1 b, 3.3.3.2a and 
3.3.3.2b listed the identified proteins with a variety of information including protein 
name, accession number, protein molecular weight, protein pi, peptide count, protein 
score, protein score C.I. %, best ion score. The proteins were also categorized 
according to their suggested biological functions: detoxification; homeostasis; 
membrane protein and transport; metabolism; nuclear transport; protein folding; 
signal transduction; stress induced protein, structural component; transcription 
repressor. 
3.3.3.1. HepG2 
The information of proteins expression difference in HepG2 cell line after receiving 
Cordyceps militaris fruiting body and mycelia extracts were displayed in Table 
3.3.3.1a and 3.3.3.1b respectively. 
· For HepG2 cells treated with Cordyceps militaris fruiting body extract, there were 
19 differentially expressed proteins being identified. Among them, 11 proteins were 
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down-regulated (heat shock 90kDa protein 1 beta, FUBP1 protein, RuvB-like 1, 
DNA-binding protein B, SET, enolase 1, unnamed protein product, citrate synthase 
precursor, aldolase A, peroxiredoxin 1 and APRIL). 8 proteins were up-regulated 
(transketolase, human serum albumin, protein disulfide isomerase- related protein 5, 
eukaryotic translation initiation factor 2 subunit 1 alpha, annexin IV, proteasome 
activator subunit 1 isoform 1, dehydrogenase/ reductase member 2 isoform 2 and 
enoyl Coenzyme A hydratase). 
For HepG2 cells treated with Cordyceps militaris mycelia extract, there were 12 
differentially expressed proteins being identified. Among them, 7 proteins were 
down-regulated (alpha actinin 4, RuvB-like 1, unnamed protein product, 
DNA-binding protein B, SET translocation isoform 1, acidic (leucine-rich) nuclear 
phosphoprotein 32 family member B and endoplasmic reticulum protein 29 isoform 
1 precursor). 5 proteins were up-regulated (transketolase, human serum albumin, 
heterogeneous nuclear ribonucleoprotein H3 isoform b, annexin IV and proteasome 
activator subunit 1 iso form 1). 
3.3.3.2. Hs68 
The information of proteins expression difference in Hs68 cell line after receiving 
- Cordyceps militaris fruiting body and mycelia extracts were displayed in Table 
3.3.3.2a and 3.3.3.2b respectively. 
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For Hs68 cells treated with Cordyceps militaris fruiting body extract, there were 7 
differentially expressed proteins being identified. Among them, 5 proteins were 
down-regulated ( dihydropyrimidinase-like 2, vimentin, tropomyosin 1 alpha chain 
isoform 4, lamin A/C isoform 2 and Rho GDP dissociation inhibitor (GDI) alpha). 2 
proteins were up-regulated (Keratin 7 and serum albumin PR02619). 
For Hs68 cells treated with Cordyceps militaris mycelia extract, there were 5 
differentially expressed proteins being identified. Among them, 4 proteins were 
down-regulated ( dihydropyrimidinase-like 2, vimentin, tropomyosin 1 alpha chain 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.4. Cell cycle analysis 
3.4.1. Cell samples preparation 
The cell lines HepG2 and Hs68 received corresponding Cordyceps militaris extracts 
treatment as mentioned in proteomic studies (section 3.3 .1) and the cells were 
harvested for PI staining before flow cytometry in cell cycle analysis. 
3.4.2. HepG2 
Cell cycle distribution of HepG2 cells after treatment with Cordyceps militaris 
fruiting body or mycelia extract for 48 hours was shown in Fig. 3.4.2a. Proportions 
of cells in G 1, S and G2/M phases were analyzed using the Multicycle AV software. 
The average amount of control HepG2 cells in G1, S and G2/M phases were 
63.36+5.86o/o, 30.91 +6.40% and 5.73+3.37% respectively. The average amount of 
CMFB-treated HepG2 cells in G1, S and G2/M phases were 72.60+3.50%, 
12.40+5.11% and 15.00+ 1.99o/o respectively and so in CMM-treated HepG2 cells 
were72.12+7.28o/o, 17.51 +8.48o/o and 10.36+4.24% respectively. Percentage of G 1 
phase and G2/M phase cells statistically increased while S phase cells dropped in 
CMFB-treated HepG2 cells when compared with the control. Similar trend was 
observed in CMM-treated HepG2 cells. There was cell cycle perturbation after 
receiving the Cordyceps extracts treatment. 
76 
3.4.3. Hs68 
Cell cycle distribution of Hs68 cells after treatment with Cordyceps militaris fruiting 
body or mycelia extract for 48 hours was shown in Fig. 3.4.3a. Proportions of cells 
in G1, S and G2/M phases were analyzed using the Multicycle AV software. The 
average amount of control Hs68 cells in G1, Sand G2/M phases were 72.97+4.91 %, 
26.40+4.86% and 0.63+0.81% respectively. The average amount of CMFB-treated 
Hs68 cells in G1, S and G2/M phases were 75.45+2.31%, 23.28+1.80% and 
1.27+ 1.20% respectively and so in CMM-treated Hs68 cells were73.61 +4.84%, 
24.97+5.22% and 1.42+ 1.57% respectively. There was no statistically significant 
difference in percentage of cells in G 1, S and G2/M phases in CMFB-treated or 
CMM -treated Hs68 cells when compared with the control. 
3.4.4. H292 
Cell cycle distribution of H292 cells after treatment with Cordyceps militaris 
fruiting body or mycelia extract for 48 hours was shown in Fig. 3.4.4a. Proportions 
of cells in G 1, S and G2/M phases were analyzed using the Multicycle AV software. 
The average amount of control HepG2 cells in G1, S and G2/M phases were 
67.36+7.61o/o, 26.81+7.12% and 5.83+3.65% respectively. The average amount of 
CMFB-treated HepG2 cells in G1, S and G2/M phases were 76.39+3.11 %, 
18.89+4.52% and 4.73+5.09% respectively and so in CMM-treated HepG2 cells 
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were77.48+8.68%, 19.09+9.53% and 3.43+4.71% respectively. Percentage of Gl 
phase cells statistically increased while S phase cells dropped in CMFB-treated 
HepG2 cells when compared with the control. Similar trend was observed in 
CMM-treated HepG2 cells. There was cell cycle perturbation after receiving the 
























Error bars: t/- 1.00 SD 
Fig. 3 .4.2a Cell cycle distribution of HepG2 cells after treatment with Cordyceps 
militaris fruiting body or mycelia extract for 48hrs. Proportions of cells in G 1, S and 
G2/M phases were analyzed using the Multicycle A V software. 
* * p<O.Ol, * p<0.05, statistically significant compared with control (n=4) 
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Error bars: +1- 1.00 SD 
Fig. 3.4.3a Cell cycle distribution of Hs68 cells after treatment with Cordyceps 
militaris fruiting body or mycelia extract for 48hrs. Proportions of cells in G 1, S and 









Error bars: +1- 1.00 SD 
Fig. 3 .4.4a Cell cycle distribution of H292 cells after treatment with Cordyceps 
militaris fruiting body or mycelia extract for 48hrs. Proportions of cells in G 1, S and 
02/M phases were analyzed using the Multicycle A V software. 
* * p<O.Ol, * p<0.05, statistically significant compared with control (n=4) 
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3.5. Western blotting 
3.5.1. Protein samples preparation 
The cell lines HepG2 and Hs68 received corresponding Cordyceps militaris extracts 
treatment as mentioned in protein samples preparation of changes in total protein 
expression profiles in section 3.3 .1 and their proteins were extracted for western 
blotting analysis. Photos of the cell lines receiving different treatment were taken 
just before they were collected for protein extraction. Fig. 3.5.1a and 3.5.1 b showed 
the morphology of the cell lines HepG2 and Hs 68 under light microscope 
respectively. 
For HepG2 cells, those treated with Cordyceps militaris fruiting body or mycelia 
extract were less packed and more irregular in shape. 
For Hs68 cells, treatment with Cordyceps militaris fruiting body or mycelia extract 













































































































































































3.5.2. Detection of actin for protein loading normalization 
Detecting the amount of actin in all the samples allowed normalization of protein 
loading amount. From the membrane image, all the samples gave a band with 45kDa 
molecular size which indicated the amount of actin present in each lane. The same 
band size and intensity in each lane suggested that same amount of proteins were 
used for comparison in cell lines HepG2 and Hs68. Corresponding membrane image 
was shown in Fig. 3.5.2. 
3.5.3. Detection of procaspase-3 and cleaved caspase-3 
For HepG2 cells, those treated with Cordyceps militaris fruiting body or mycelia 
extract at their corresponding IC50 concentrations gave a decrease in the amount of 
procaspase-3 (35kDa) when compared with the control cells. They were confirmed 
for the present of cleaved caspase-3 (19kDa) detected using another antibody 
specific for only the cleaved products. 
In Hs68, the amount of procaspse-3 remained unchanged upon treating with 
Cordyceps militaris fruiting body or mycelia extract. Also, none of the cleaved 
caspase-3 was detected in the corresponding samples when compared with the 
control. 
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3.5.4. Detection of procaspase-7 and cleaved caspase-7 
The HepG2 cells treated with Cordyceps militaris fruiting body or mycelia extract at 
their corresponding IC5o concentrations gave a decrease in the amount of 
procaspase-7 (35kDa) when compared with the control cells. They were positive for 
the present of cleaved caspase-7 (20kDa) but not the control. 
In Hs68, the amount of procaspse-7 remained unchanged upon treating with 
Cordyceps militaris fruiting body or mycelia extract. Also, none of the cleaved 
caspase-7 was detected in the corresponding samples when compared with the 
control untreated cells. 
3.5.5. Detection of procaspase-9 and cleaved caspase-9 
The HepG2 cells treated with Cordyceps militaris fruiting body or mycelia extract at 
their corresponding IC50 concentrations gave a decrease in the amount of 
procaspase-9 ( 4 7kDa) when compared with the control cells. They were positive for 
the present of cleaved caspase-9 (37kDa) but not the control. 
In Hs68, the amount of procaspse-9 remained unchanged upon treating with 
Cordyceps militaris fruiting body or mycelia extract. Also, none of the cleaved 
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Fig. 3.5.2 Membrane iinage of the samples from cell lines HepG2 and Hs68 




4.1. Anti-tumor proliferating effect of Cordyceps extracts 
From the results of MTT assay, both Cordyceps militaris fruiting body and mycelia 
extracts could inhibit the growth of cancer cell lines (HepG2, H292 and Neuro2a) in 
a dosage-dependent manner. Fruiting body extract always had a lower IC50 values 
than mycelia extract. Both Cordyceps militaris fruiting body and mycelia extracts 
were found to have a higher anti-tumor proliferation activity than not just the 
Cordyceps sinensis extracts, but also the 2 bio-makers - cordycepin and adenosine. 
They showed little or no inhibitory effect on the Hs68 and WIL2-NS normal cells. 
These results suggested that Cordyceps militaris extracts possessed selectivity 
between cancer and normal cells and might be potent anti -cancer drugs. 
The IC50 value of our cultivated Cordyceps militaris fruiting body extract (0.0085 
mg/ml) was very low. It was far lower than the corresponding value found by Lee, et 
al. in HL-60 human myeloid leukemia cell line (0.8 mg/ml) (Lee, et al., 2006). Such 
great difference could not be explained by only the difference in used cell line. We 
suggested the boiling water method they used for extract preparation would cause 
some of the bioactive ingredients degrade, so they were required a higher dose for 
anti-tumor proliferation. Besides, our labmate had proved that the extraction method 
sonication was better than water boiling in anti-tumor proliferating assay of 
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Cordyceps (Lai, unpubished). 
In the anti-proliferation assay, it is clear the use of corresponding normal human cell 
lines would be better when comparing with different human cancer cell lines. 
However, it is difficult for us to obtain such normal human cell lines from primary 
culture. Therefore, the normal cell line Hs68 was chosen as the control cell line. 
Hs68 was generally used as a control in similar stuies (Chen, et al., 2009. Liu, et al., 
2009). 
4.2. Changes in total protein expression profiles in cell lines 
Life science research has undergone a revolutionary change over the decade driven 
by the advance in molecular biotechnology. The sequence of human genome has 
been mostly determined and opened new visions on its complexity and network of 
biological processes. In genomic era, genome-wide mRNA profiling were applied 
and made high throughput RNA-sequencing the method of choice for the analysis of 
gene expression, which the expression of protein coding genes were compared. The 
drawback of this approach was that target genes were missed when protein 
expression was only regulated at the translational level. An often cited observation 
was the lack of obvious correlation between intracellular mRNA abundance and 
protein expression level (Anderson, et al., 1997; Griffin, et al., 2002). Therefore, 
network analysis should be extended to protein profiling within the cells or tissues, 
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which comes the field of proteomics. 
2D gel electrophoresis and mass spectrometry were important tools in proteomic 
studies, which contributed greatly to systematic and quantitative understanding of 
complex biological system. As any perturbation of the cell resulted in a multi protein 
response, an ideal study should involve the simultaneous measurement of all the 
proteins related for multiple comparisons and meaningful data interpretation. Thus, 
the whole cell proteome was chosen as the study model in selected cancer or normal 
cell lines. An alteration in protein abundance implicated its involvement in various 
cellular events like signal transduction, energy pathway, redox regulation, 
physiological stages progression, and they would be described in following sections. 
4.2.1. Differentially expressed proteins in HepG2 treated with fruiting body 
extract 
For HepG2 cells treated with Cordyceps militaris fruiting body extract, there were 19 
differentially expressed proteins being identified. Among them, 11 proteins were 
down-regulated (heat shock 90kDa protein 1 beta, FUBP1 protein, RuvB-like 1, 
DNA-binding protein B, SET, enolase 1, unnamed protein product, citrate synthase 
precursor, aldolase A, peroxiredoxin 1 and APRIL). 8 proteins were up-regulated 
(transketolase, human serum albumin, protein disulfide isomerase- related protein 5, 
eukaryotic translation initiation factor 2 subunit 1 alpha, annexin N, proteasome 
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activator subunit 1 isoform 1, dehydrogenase/ reductase member 2 isoform 2 and 
enoyl Coenzyme A hydratase). Some of them were chosen for discussion. 
4.2.1.1. Heat shock 90kDa protein 1 beta (HSP90P) 
The ATP-dependent chaperone HSP90 comprised 2 isoforms (HSP90a and HSP90~) 
that regulated correct protein folding, translocation and proteolytic turnover of many 
of the key regulators of cell growth, differentiation and survival. HSP90s were 
overexpressed in many cancers, and their guardian function was subverted during 
oncogenesis to allow malignant cells transformation and to tolerate rapid somatic 
evolution. Many oncogenic proteins have been found as HSP90s client proteins 
(Sreedhar, et al., 2004). They were dominated by kinases, hormone receptors and 
transcription factors, liked HER-2/ErbB2, Akt, Raf-1, Bcr-Abl and mutated p53 
(Whitesell, et al., 2005). Thus, HSP90 has emerged as an exciting target for cancer 
chemotherapy. The potential of HSP90 inhibitors to cause simultaneous depletion of 
multiple oncogenic client proteins and the antagonism of all of the hallmark 
pathological traits of malignancy, including the self-sufficiency in growth signals, 
insensitivity to antigrowth signals, evasion of apoptosis, limitless replicative 
potential, sustained angiogenesis, and tissue invasion and metastasis (Xu, et al., 2007; 
Mahalingam, et al., 2009). Some of them have entered the clinical trials and been 
reviewed (Solit, et al., 2008). 
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4.2.1.2. Far upstream element-binding protein 1 (FUBP-1) 
FUBP -1 was a binding factor to single stranded far upstream sequence element 
(FUSE), a positive cis-element of c-myc. It has been demonstrated that the binding of 
FUBP to the extended promoter region (FUSE) and its interaction with other 
transcriptional factors is essential for tight regulation of c-myc expression (Chung, et 
al., 2005). C-myc played a critical role in cell proliferation and increased levels of 
this proto-oncogene have been observed in different tumors including hepatocellular 
carcinoma (Feitelson, et al., 2004). Overexpression of the upstream player FUBP has 
been proposed as a candidate for the liver carcinogenesis by modulating the c-myc 
levels. FUBP was found down-regulated in tumor cells treated with anti-cancer agent 
(Zubaidah, et al., 2008). In vitro studies of knocking down FUBP caused the cell 
proliferation arrest and showed a significant decrease in c-myc level (He, et al., 
2000). Our Cordyceps militaris fruiting body extract caused FUBP down-regulation 
which affected the cell cycle progression. 
4.2.1.3. RuvB-Iike 1 (RuvbL1) 
RuvbLl (also known as pontin, RVBl, TIP49, TIP49A, IN080H, TIHl and ECP54) 
was a highly conserved ATP-binding protein that belonged to the AAA+ (ATPase 
associated with diverse cellular activities) family of ATPase. It has been implicated in 
many cellular events with its appearance 1n diverse cellular protein complexes. 
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RuvbLl was a part of various chromatin-remodeling complexes (TIP60, Ino80, Swrl) 
in regulating the accessibility of DNA to the proteins involved in transcription 
activation or repression. It might seem RuvbLl act antagonistically at molecular 
level but the events involved favor the tumor progression. RuvbLl took part in DNA 
damage repair machinery by regulating the position or modification of nucleosomes. 
RuvbLl has been recruited in cellular transformation by Myc and ~-catenin, and in 
the assembly and maturation of ribonucleolar protein (RNP) including the snoRNPs 
and telomerase. Depletion of endogenous RuvbLl by siRNA reduced the levels of 
snoRNAs. The interaction of RuvbLl with chromatin- assembly factors and tubulin 
suggested its function in DNA replication and mitosis. Our results demonstrated the 
down-regulation of RuvbLl by Cordyceps militaris fruiting body extract which 
caused molecular lesion tn vanous biochemical complexes leading to 
anti-proliferation in cancers (Huber, et al., 2008; Jha, et al., 2009). 
4.2.1.4. Acidic protein rich in leucine (APRIL) 
It encoded the acidic protein rich in leucine which belonged to the evolutionarily-
conserved leucine-rich acidic nuclear protein family (Anp32), that were 
characterized by leucine-rich repeats (LRR) at amino- terminal and a carboxyl-
terminal acidic tail. Recent findings indicated conserved roles of the Anp32 family 
members during evolution in the modulation of cell signaling and transduction of 
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gene expression to regulate the morphology and dynamics of the cytoskeleton, cell 
adhesion, neural development or cerebella morphogenesis. For APRIL, it was also 
known as Anp32b, PHAPI2a/ 2b, PAL31 and Ssp29. It was found in 
highly-proliferating tissues (Matilla, et al., 2005). Proliferation-related acidic nuclear 
protein (PAL31) was originally discovered in fetal rat brain. It was required for cell 
cycle progression from the G 1 to S phase in mitogens treated murine lymphocytes 
(Sun, et al., 2001). Then, PAL31 was indicated as a caspase-3 inhibitor in rescuing 
murine cells form etoposide and UV radiation induced apoptosis and providing 
cytoprotection (Sun, et al., 2006). Suppressing the PAL31 translation by antisense 
oligonucleotide inhibited the lymphocytes proliferation and induced apoptosis. 
Though the studying model of this protein was usually the lymphocytes, we 
suggested the cut down of the protein might pose similar effect on the liver cancer 
cells. Besides, its interaction with RNA polymerase I suggested that it might regulate 
ribosomal RNA biosynthesis (Zhu, ed al., 1997). 
Moreover, it has been identified that Anp32b was a histone chaperone involved in 
promoter region-specific histone incorporation and regulating chromatin in 
eukaryotic transcription (Munemasa, et al., 2008). 
4.2.1.5. SET protein 
SET, was also known as I2PP2A, played a critical role in many essential cellular 
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processes such as chromatin remodeling, apoptosis and cell cycle progression by 
interacting with a variety of partners (Vera, et al., 2007). In term of tumorigenesis, 
SET was over-expressed in solid tumors and leukemia and leaded to PP2A inhibition. 
PP2A, protein phosphatase 2A, participated in normal cell homeostasis by 
dephosphorylating substrates, and so providing a negative feedback to signals 
triggered by kinases. It is involved in mitogenic and survival signals transduction 
pathways, transcription and translational regulation, DNA replication and cell cycle 
control. Therefore, PP2A was designated as 'tumor suppressor' and its inhibition of 
phosphatase activity was widely accepted in associating with malignant 
transformation. For example, I2PP2A increased the concentration, phosphorylation 
and DNA binding of the proto-oncogene c-Jun, as well as the transcriptional activity 
of the activator protein-1 (AP-1) transcription-factor complex (Al-Murrani, et al., 
1999). Similarly, I2PP2A prevented ceramide-mediated c-Myc degradation via its 
PP2A-dependent dephosphorylation at S62 and anti-proliferation (Mukhopadhyay, et 
al., 2009). Several PP2A activators have been proven effective in leukemia in vivo 
studies and also entered clinical trials (Perrotti, et al., 2006; Perrotti, et al., 2008). 
From our proteomic studies, we suggested the possibility of Cordyceps militaris 
fruiting body extract in restoring PP2A activity via SET down-regulation. It may be 
the first time demonstrating the therapeutic relevance of such Cordyceps extract in 
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liver cancer via this mechanism by in vitro model and it should be further evaluated. 
In addition, SET reversed the inhibitory effect of cyclin-dependent kinase (CDK) 
inhibitor p21 (Cip 1 ), that p21 prevented premature activation of cyclin E-Cdk2 
complexes that form during GO or early G 1 (Estanyol, et al., 1999). But SET and p21 
cooperated in the inhibition of cyclin B-Cdk1 activity and blocked G2/M transition 
(Canela, et al., 2003). These results indicated that SET might regulate cell cycle 
checkpoints transition by modulating different cyclin-Cdk complexes activity. 
Recently, the SET oncoprotein was identified as an inhibitor of the cytotoxic T 
lymphocyte (CTL) - induced cell apoptosis through the granzyme A (GzmA) 
activated DNase (GAAD) complex (Fan, et al., 2003). 
The current view suggested that transcription factors regulated the recruitment and 
assembly of multiple components in coactivator complexes that possessed histone 
acetyltransferase activity on gene promoters to facilitate transcription. SET was 
recruited in the complexes and exerted its effect by modulating the acetylase activity 
and/ or through remodeling of the promoter's chromatin structure. How SET 
temporally and spatially regulated transcription might provide a potential role in 
pathogenesis in malignancies (Karetsou, et al., 2005). 
4.2.1.6. Enolase 1 (a-enolase) 
Enolase was one of the abundant cytosolic proteins in organisms. In vertebrates, this 
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enzyme occurred as 3 isozymes, which a-enolase was found in a variety of tissues 
including liver, spleen, kidney and adipose tissue. Structural and expression analysis 
have discovered the multifunctional nature of enolase according to pathophysiology, 
metabolic or developmental conditions (Aaronson, et a!., 1995; Subramanian, et a!., 
2000; Lopez-Alemany, et a!., 2005). In proteomic studies, evidenced at cytosolic 
protein level, we considered its innate glycolytic function for energy generation. 
a-enolase was a metaloenzyme that catalyzed the dehydration of 2-phosphoglycerate 
to phosphoenolypyruvate in catabolic direction. Glycolysis was an essential cellular 
process especially for the energy demanding cancer cells, and there was clinical 
correlation of a-enolase over-expression with various cancerous progression and 
metastasis (Pancholi, 2001 ). Our Cordyceps extract could reduce the energy supply 
to cancer cells through glucose metabolism retardation. 
A German biochemist Otto Heinrich Warburg was the first to report that liver cancer 
cells, when compared to normal liver tissue, were characterized by an increase in 
glycolytic activity even in the presence of oxygen. The underlying mechanisms of 
Warburg effect, a metabolic shift from the mitochondrial oxidative phosphorylation 
to glycolysis, needed investigation. Additional work should be required to resolve 
"the chicken and egg" dilemma, such that Warburg effect is a symptom or the cause 
of carcinogenesis (Warburg, 1956, Chen, eta!., 2007; Zhivotovsky, et al., 2009) No 
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matter of this, we observed the reduction of the glycolytic enzyme in cancer cells 
treated by Cordyceps extract and their proliferation was not favored. 
4.2.1. 7. Aldolase A 
Aldolase A took part in the glycolytic pathway in converting the fructose-!, 6-
bisphosphate into dihydroxyacetone phosphate. Its over-expression was observed in 
various cancers including pancreatic, prostate, adrenocortical and renal cancers. With 
the property as a biomarker, its down-regulation was observed when the investigation 
models were treated with potential anti-tumor agents (Craven, et a!., 2006; van den 
Bernd, et al., 2006; Sundravel, et al., 2006; Stigliano, et al., 2008). The observation 
of aldolase A down-regulation in the Cordyceps militaris fruiting body extract treated 
liver cancer cells supported its anti-tumor proliferation property. The reduction of 
this glycolytic enzyme cut down the energy supply to cancer cells, which depended 
heavily on glycolysis. Detailed explanation can be referred to section 4.2.1.6. 
4.2.1.8. DNA-binding protein B 
DNA-binding protein B, an alternative name of Y-box binding protein 1 (YB-1 ), 
which was a multifunctional DNA/ RNA binding protein belonging to the cold shock 
domain family widely appeared from bacteria to mammals (Matsumoto, eta!., 1998). 
Highly expressed YB-1 was necessary for maturation and differentiation of 
hepatocytes in fetal liver. Normally, it was absence in normal adult liver, but it was 
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re-expressed during regeneration of injured liver. These indicated a positive 
correlation between YB-1 expression and cell proliferation. Molecular mechanisms 
were suggested for the presence of Y-box sequence motif in the promoter regions of 
the growth-associated eukaryotic genes (Kohno, et al., 2003). It was not surprising 
that YB-1 was considered as a tumor marker for human hepatocellular carcinoma 
(HCC), and YB-1 promoted proliferation of breast, lung, ovary and prostate cancer 
cells (Yasen, et al., 2005). YB-1was shown to be up-regulated by oncoprotein c-Myc 
in cancer cells, so YB-1 might be involved in the c-Myc mediated signaling cascade 
in liver. YB-1 was cell cycle stage specific, which moved to nucleus between G 1 and 
S phases. Overexpression of YB-1 enhanced cyclin A expression, which contributed 
to adhesion-independent cell growth (Jurchott, et al., 2003). Form this, we suggested 
Cordyceps fruiting body extract might affect the progression of cancer cells in S 
phase by down-regulating YB-1. 
4.2.1.9. Peroxiredoxin 1 (Prx 1) 
Peroxiredoxins (Prxs) have been recently discovered as family of the thiol 
peroxidases. These highly-conserved ubiquitous antioxidant enzymes were expressed 
at high levels in cells and they played an important role in cell peroxide and 
peroxynitrate detoxification. Prx 1 belonged to the 2-Cys Prx subgroup, which 
contained 2 conserved Cys residues involved in the peroxidase activity. Its 
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peroxidatic residue Cys51 (CP) attacked the 0-0 bond of the peroxide and itself to 
form sulfenic derivative CP-SOH. It then formed intermolecular disulfide bond with 
the resolving residue Cys 173 (CR). This transient bond formation was necessary for 
reducing back to CP-SH by the reduced thioredoxin and completed a cycle of 
peroxide catalysis by Prx 1. Without this enzymatic antioxidative system, the reactive 
oxygen species as by-product of cellular metabolism are toxic at high levels in 
eukaryotic cells (Rhee, et al., 2005; Abbas, et al., 2008). However, the CP of 
eukaryotic 2-Cys Prx 1 was vulnerable to hyperoxidation to sulfinic ( -S02H) and 
sulfonic ( -S03H) acids and lost its peroxidase activity. This hyperoxidized Prx 1 
tended to form a more compact decamer than that of fully reduced Prx. Recent 
studies suggested this Prx decamer might function as a molecular chaperone (Seo, et 
al., 2009; Lee, et al., 2007). Prxs were functionally versatile and aberrant regulation 
of Prxs has been discovered in various cancers. Elevated expression of Prx 1 was 
found associated with thyroid, oral, breast, bladder cancers. As the hypoxic and 
unstable oxygenation microenvironment of tumor was one of the key factors 
influencing tumor growth and progression, the induction of Prx 1 expression might 
be an adaptive response. In our studies, Cordyceps extract posed reverse effect of Prx 
1 expression and it might reduce the survival ability of cancer cells in the stressful 
microenvironment (Zhang, et al., 2009). 
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4.2.1.10.Proteasome activator subunit 1 isoform 1 
The 26S proteasome was responsible for the recycling proteolysis of most 
intracellular proteins yet the focus of intense regulation itself. The proteasome 
configurations were very dynamic contributing to its diverse activities. Various 
closely associating proteins enhanced complex stability, modulated activity, assisted 
in substrate-binding and recycling of ubiquitin, etc. This proteasome activator 
subunit (PA28a) was non-ATPase activator, formed alternate cap in proteasome but 
its physiological roles were unclear. It suggested the proteasome activator altered the 
peptidase activities of 20S core protein, which was responsible for the production of 
antigenic peptides and was linked to immune response. PA28a did not confer the 20S 
proteasome ability to degrade intact or ubiquitous proteins (Ahn, et al., 1996; 
Schmidt, et al., 2005). Increased of this proteasome activator after administration of 
Cordyceps fruiting body extract might induce immune response targeting the cancer 
cells. 
4.2.1.11.Dehydrogenase/ reductase member 2 isoform 2 
It is the protein Hep27, which was synthesized in human hepatoblastoma HepG2 
cells induced by butyrate treatment. Butyrate inhibited DNA synthesis and caused 
growth arrest in HepG2 cells, such that the G 1-arrested cells were stated to be in the 
GO phase. The incompatibility between Hep27 expression and cell proliferation 
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suggested Hep27 might play a role in sustaining the quiescence status of the cells. 
The predicted amino acid sequence from translation of Hep27 eDNA indicated the 
Hep27 was a member of the short-chain dehydrogenase/ reductase enzymes (SDR 
family) (Donadel, et al., 1991; Pellegrini, et al., 2002). Its augmenting expression in 
Cordyceps fruiting body extract treated HepG2 cells suggested the extract might lead 
to G 1 phase arrest. 
4.2.1.12.Protein disulfide isomerase- related protein 5 
Protein disulfide Isomerase (PDI) catalyzed the oxidation, reduction and 
isomerization of disulfide bonds in proteins in vitro. It accelerated the folding of 
disulfide- bonded proteins by catalyzing the disulfide interchange reaction, a rate-
limiting step during protein folding in endoplasmic reticulum (ER). Protein disulfide 
isomerase- related protein (PDirp) held 3 thioredoxin- like domain (CXXC motif), 
which was responsible for its thiol-disulfide bond exchange activity. The structural 
features, cellular compartmentation, tissue distribution and stress inducibility of 
PDirp revealed its resemblance with PDI (Hayano, et al., 1995). In our studies, 
PDirp upregulation indicated the cancer cells HepG2 were under stress and PDirp 
was induced to assist the refolding of proteins denatured by the stress. 
4.2.1.13.Annexin IV 
Annexins were a family of calcium-dependent phospholipids binding proteins. There 
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were 13 members and they showed cell type specific expression. They had been 
involved in various biological functions including vesicle trafficking, cell division, 
calcium signaling and growth regulation. In relating to hepatocellular carcinoma, 
there were increased expression of annexin AI and A2 but the loss of annexin AIO 
was associated with poor prognosis (Mussunoor, et al., 2008). We have demonstrated 
an increased in annexin A4 after treating the HepG2 cells with Cordyceps fruiting 
body extract. The expression of annexin A4 was shown to be induced in lung cancer 
under cytotoxic stress by receiving anti-cancer drug Paclitaxel (Han, et al., 2000). It 
explained the Cordyceps extract posing similar anti-proliferating effect on the cancer 
cells. 
4.2.1.14.Enoyl Coenzyme A hydratase 
In beta-oxidation, two carbons at a time were cleaved from fatty acyl-CoA thioester 
starting at the carboxyl end, and the two-carbon units formed were acetyl-CoA. Beta 
oxidation of saturated fatty acids consisted of a recurring cycle of a series of four 
steps. Enoyl-CoA hydratase was involved in the second step. Only the enoyl-CoA 
hydratase being increased but not the other correlated members, it was hard to 
determinate if the fatty acids metabolism was increased. Further investigation should 
be required. 
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4.2.2. Differentially expressed proteins in HepG2 treated with mycelia extract 
For HepG2 cells treated with Cordyceps militaris mycelia extract, there were 12 
differentially expressed proteins being identified. Among them, 7 proteins were 
down-regulated (alpha actinin 4, RuvB-like 1, unnamed protein product, 
DNA-binding protein B, SET translocation isoform 1, acidic (leucine-rich) nuclear 
phosphoprotein 32 family member B and endoplasmic reticulum protein 29 isoform 
1 precursor). 5 proteins were up-regulated (transketolase, human serum albumin, 
heterogeneous nuclear ribonucleoprotein H3 isoform b, annexin IV and proteasome 
activator subunit 1 isoform 1 ). Some of the proteins showed similar alterations as the 
cells treated with fruiting body extract and they have been discussed in previous 
section. 
4.2.2.1. Alpha actinin 4 
Previous studies have demonstrated cytoplasmic contractile apparatus of cancer cells 
was more developed and that explained the invasive activity of malignant cells 
(Gabbiani, 1979). a-actinin was thought to cross-link with actin filaments and 
connect the actin cytoskeleton to the cell membrane. Distinct isoforms had been 
characterized and their differences included calcium sensitivity and interactions with 
actin. a-actinin was thus participated in cell shape changes and cellular migration in 
regulation of cell function (Honda, et a!., 1998). A striking increase in a-actinin 
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expression was found in HCC tissue when compared with adjacent uninvolved liver 
tissue. However, there was no increase in a-actinin expression in rats after two-thirds 
hepatectomy. This suggested a-actinin may be required for the transformation 
phenotype during carcinogenesis (Nishiyama, eta!., 1990). Thus Cordyceps mycelia 
extract had a reverse effect on the malignant phenotype of cancer cells by reducing 
the a-actinin expression. 
4.2.2.2. SET translocation isoform 1 
Refer to section 4.2.1.5 for the SET protein. 
4.2.2.3. Acidic (leucine-rich) nuclear phosphoprotein 32 family member B 
(ANP32b) 
Refer to section 4.2.1.4 for the acidic protein rich in leucine (APRIL). 
4.2.2.4. Endoplasmic reticulum protein 29 isoform 1 precursor (ERp29) 
Chaperone within the ER assisted in maturation and transportation of many secretory 
proteins. One of the major protein families in ER, PDI-related family, carried out the 
functions of disulfide bond formation and reduction as well as chaperone activity by 
noncovalent interaction with the thioredoxin domain. Human ERp29, belonged to 
PDI-D~, was unable to catalyze the disulfide bond formation but it had a cysteine 
residue Cys125 participating in disulfide bond editing (Mkrtchian, et a!., 2006; 
Hermann, eta!., 2005). 
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ERp29 was reported to be essential for post-translational modification and/ or 
secretion of natural substrates such as thyroglobulin and connexin 43 (Baryshev, et 
al., 2006; Das, et al., 2009). ERp29 was up-regulated concurrently with various 
physiological and pathological stress conditions including carcinogenesis, which 
required the increase in folding and secretory capacity of ER. It was suggested that 
cancer cells interacted with the microenvironment by cell-cell and cell-matrix contact 
and/ or through secretion of soluble factors. ERp29 was found contributing to the 
growth and aggression of breast cancer cells and basal cell carcinoma (Mkrtchian, et 
al., 2008; Cheretis, et al., 2006). Down regulation of the ERp29 precursor might 
reduce the supply of the quickly turnover ERp29. With reduction of chaperone 
activity in cancer cells, mycelia extract might cause more protein misfolding and 
drop of secretory capacity. This did not favor the cancer cell survival and invasion. 
4.2.2.5. Heterogeneous nuclear ribonucleoprotein H3 isoform b (hnRNP 2H9A) 
Heterogeneous nuclear ribonucleoproteins (hnRNPs) were ubiquitously expressed 
and they complexed with heterogeneous nuclear RNA (hnRNA) generated form the 
RNA polymerase II. The hnRNP family proteins shared the structural domain of 
RNA recognition motif (RRM) and they showed sequence specific binding properties. 
HnRNPs affected the pre-mRNA processing and other aspects of mRNA metabolism 
and transport, which were involved in different cellular roles. Thus hnRNPs 
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regulated tumorigenesis relating to different events such as telomere biogenesis, 
inhibition of proliferation/ apoptosis, angiogenesis and metastasis. They might 
promote and inhibit cancers by regulating different genes downstreaming (Carpenter, 
et al., 2006). The subfamily gene hnRNP 2H9 encoded six isoforms through 
alternative splicing. The resulting isoforms showed great structural variations and 
reflected their diverse functions (Honore, 2000). However, which specific functions 
each of the various hnRNP 2H9 members serves in different tissues now remains to 
be investigated. 
4.2.3. Differentially expressed proteins in Hs68 treated with fruiting body 
extract 
For Hs68 cells treated with Cordyceps militaris fruiting body extract, there were 7 
differentially expressed proteins being identified. Among them, 5 proteins were 
down-regulated ( dihydropyrimidinase-like 2, vim en tin, tropomyosin 1 alpha chain 
isoform 4, lamin A/C isoform 2 and Rho GDP dissociation inhibitor (GDI) alpha). 2 
proteins were up-regulated (Keratin 7 and serum albumin PR02619). 
4.2.3.1. Lamin A/C isoform 2 
Lamins were type V intermediate filament proteins that formed a filamentous 
network underlying the inner nuclear membrane, termed as lamina. Its main function 
was to maintain nuclear architecture and integrity. Lamin A/C especially contributed 
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to the nuclear mechanical stiffness but lamin A deficient cells had no increase in 
susceptibility to cell death in response to stress (Lammerding, et a!., 2006). 
Interactions between lamins and nuclear proteins suggested the roles of lamins in 
chromatin organization, gene regulation and signaling transduction (Gruenbaum, et 
a!., 2005). There was no systematic correlation between lamin A/C expression and 
malignancies. Lamins expression pattern was complicated and their aberrations were 
affected by cancer subtypes, differentiation state and aggressiveness (Prokocimer, et 
a!., 2006). Thus, there was no supporting data in the tumorigenic trend in Hs68 cells 
for its lamin A/C down-regulation. 
Besides, the caspase-dependent degradation of lamin A/C preceded nuclear 
destruction 1n programmed cell death (Rao, et a!., 1996). Hs68 cells did not 
developed apoptotic morphologies like nuclear shrinkage and apoptotic bodies 
formation. To evaluate if there was a progression of apoptosis in Hs68, western blot 
for the caspases would be conducted. 
4.2.3.2. Vimentin 
Vim en tin belonged to type III intermediate filaments which were one of the major 
structural components of the cytoskeleton. The main intracellular functions of 
vimentin, based on its mechanical properties and self-assembly ability, was the 
maintenance of cell and tissue integrity, as well as distribution of organelles and 
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proteins (Wang, et al., 2002; Minin, et al., 2008). Besides, it was involved in cell 
adhesion and migration (Ivaska, et al., 2007). Such diverse functions of vimentin 
were through its interaction with many structures and individuals protein, together 
with the control of signaling processes. 
Vimentin could interact with lamins and this suggested a direct and specific 
interaction between elements of cytoplasmic matrix and peripheral elements of 
nuclear matrix through the nuclear pore complexes (Geiger, 1987). It seemed to 
come down with lamin proteins contributing to structural fragility. Disappearance of 
vimentin was demonstrated as preapoptotic signals in drug-induced apoptotic cells 
(Tay, et al., 2007). However, the possibility of apoptosis needed to be confirmed with 
some other assays. 
4.2.3.3. Tropomyosin 1 alpha chain isoform 4 
Tropomyosin (Tm) was a dimeric a-helical coiled protein of the cytoskeleton that 
bound to actin filaments of muscle and nonmuscle cells. Multiple isoforms were 
generated from four mammalian genes (a, ~, y and 8), which alternative splicing 
accounted for the creation of >40 isoforms. Tm isoforms profile varied from tissues 
and developmental stages (Schevzov, et al., 2005; Perry, 2001). Evidence of discrete 
Tm isoforms associating with specific microfilaments suggested defined cytoskeletal 
populations were enable to perform specific cellular functions such as cell motility 
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and division (Lin, et a!., 2008). Alteration 1n cytoskeletal dynamics was an 
underlying problem in many disease states including cancer. Loss of contact 
inhibition, changes in cell adhesiveness, motility and morphology were highly 
related to cellular tumorigenicity, which suggested fundamental roles of 
cytoskeletons in oncogenic transformation. It was accompanied by down-regulating 
high molecular weight Tml in various tumor models (Stehn, eta!., 2006; O'Neill, et 
a!., 2008). Restoration of Tml expression reversed some tumorigenic phenotypes. 
However, there was no research conducted on normal fibroblast, so we do not 
confirm the correlation between Tml down-regulation and possibility of 
tumorigenicity. 
In another point of view, cytoplasm took a role in extracellular execution phase of 
apoptosis. In the model proposed, the first stage was the cell released extracellular 
matrix attachment and reorganized focal adhesion, adopting a more 'spherical' 
morphology. The outward changes came with loss of stress fibers, actin 
reorganization and microtubule disassembly. Caspases were implicated in this release 
phase, as many cell types did not begin morphological manifestations of the 
execution phase unless effecter caspases were activated (Mills, et al. , 1999). In Hs68 
fibroblasts, they developed some marginal changes like the release stage. They 
somehow had spreading-out shape with smoothing edge rather than 'round up ' 
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morphology and they might have Tm associated actin disturbance but not actin 
reorganization in cortical rings for blebbing. By conservative prediction, we cannot 
ignore the possibility of apoptosis, so the caspases detection by irnrnunoblotting 
would be conducted. 
4.2.3.4. Rho GDP dissociation inhibitor (GDI) alpha (RhoGDia) 
Rho family GTPases (Rho, Rae, Cdc42) regulated the assembly and organization of 
actin cytoskeleton (Nobes, et a/., 1995). The roles extended beyond to cellular 
morphology and migration, gene transcription, cell cycle progression and cytokinesis, 
etc (Vega, et al., 2008). RhoGDI could negatively regulate Rho proteins in three 
ways, shielding the membrane-anchoring domain of GTPase and restricting them to 
cytosolic nonactive localization; blocking interaction with guanine nucleotide 
exchange factor (GEF) and so inhibiting GTPase activation; and blocking binding to 
downstream target molecules. Thus, overexpression of RhoGDI in various cell lines 
induced disruption of actin cytoskeleton and loss of adherence, and microinjection of 
RhoGDI into fibroblasts inhibited cell motility (Leffers, et a!., 1993; Kishi, et a!., 
1993). In short, we are uncertain for the effect in down-regulation of RhoGDI and its 
underlying mechanistic explanation. 
4.2.3.5. Dihydropyrimidinase-like 2 (DRP-2) 
Human dihydropyrimidinase-related protein 2 (DRP-2/ CRMP-2) belonged to DRP 
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family as homology to dihydropyrimidinase (DHP). DRP-2 was implicated in axonal 
growth and its dysfunction might result in neurodevelopment abnormalities like 
schizophrenia (Inagaki, et al., 2001; Byk, et al., 1996). 
For its mechanism, DRP-2 bound to tubulin heterodimers to enhance microtubule 
assembly, which helped in the axonal elongation (Fukata, et al., 2002). In neurons, 
DRP-2 was phosphorylated in order to regulate polarization. Similarly, 
hyperphosphorylation of DRP-2 was observed in non-neuronal tumor-derived cell 
lines (Tahimic, et al., 2006). From our result, deregulation of DRP-2 might affect cell 
proliferation by disruption in protein level or phosphorylation in certain amino acid 
residues. 
4.2.3.6. Keratin 7 (K7) 
Keratins were the largest subgroup of intermediate filaments and were classified as 
type I and II (acidic and basic keratins respectively). Experimental evidence 
accumulated suggested the involvement of keratins in broadly define functions such 
as structural support, cytoarchitecture, stress response, regulation of signaling 
pathways toward apoptosis and protein synthesis, and as well organelle/ vesicle 
distribution. 
As part of their diversity in members, structures and tissue-specific expression, 
keratins served as important histological markers and manifested a highly dynamic 
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expresston profile during embryogenesis and stress conditions. Potentially be 
involved in diseases, some keratins had attained diagnostic importance, which 
consisting of K5, 7, 8/18, 19 & 20. For K7, it was detected in fetal hepatoblast for 
embryogenesis and in chronic kidney damage. However, the functional implications 
of the distribution and the function of less abundant keratins (K7, 19, 20 & 23) were 
poorly understood (Arin, 2009, Omary, et al., 2009). 
4.2.4. Differentially expressed proteins in Hs68 treated with mycelia extract 
For Hs68 cells treated with Cordyceps militaris mycelia extract, there were 5 
differentially expressed proteins being identified. Among them, 4 proteins were 
down-regulated ( dihydropyrimidinase-like 2, vimentin, tropomyosin 1 alpha chain 
isoform 4 and lamin AJC isoform 2). Only protein Keratin 7 was up-regulated. Since 
the proteins expression difference resembled similar trend as the cells treated with 
fruiting body extract, they have already been discussed in the previous section. 
4.3. Cell cycle analysis 
For HepG2 cells, its percentage of G 1 phase and G2/M phase cells statistically 
increased whileS phase cells dropped in CMFB/ CMM-treated cells. There was cell 
cycle perturbation after receiving the Cordyceps extracts treatment such that the 
entry form G 1 to S phase was hindered. This coincided with the results in the 
proteins expression difference such that the APRIL, SET protein and DNA-binding 
111 
protein B were down-regulated and dehydrogenase/ reductase member 2 isoform 2 
was increased. Such changes might lead to G 1 phase arrest. 
In another point of view, both the CMFB and CMM extracts might cause a 
prolongation of the cell cycle rather than a strict growth arrest. In fact, FUBP-1 
protein down-regulation could lead to reduction of c-myc oncoprotein. Mateyak, et al. 
had demonstrated that cells devoided of c-myc and lacking compensatory changes in 
one of the other myc proteins almost tripled their doubling time. Prolongation of G 1 
and G2 accounted for the slower growth of the cells as the duration of S phase was 
not increased, so there was a smaller S phase fraction (Mateyak, et al., 1997). This 
might explain the results observed in the cell cycle analysis for HepG2 and H292 
cancer cells, but it should be further evaluated by counting the cell number over the 
treatment period and deducing the doubling time. No matter what mechanism was 
applied, the proliferation of cancer cells was affected. 
In Hs68 cells, neither CMFB nor CMM caused statistically significant difference in 
percentage of cells in G 1, S and G2/M phases when compared with the control. 
There was no significant cell cycle perturbation in normal fibroblasts although there 
was proteins expression difference after receiving the Cordyceps extracts. It was 
acceptable for the normal fibroblast cells to cope with the extracts treatment while 
the cancer cells HepG2 and H292 were more sensitive to the extracts. 
112 
4.4. Western blotting 
For either CMFB or CMM extract, it could elicit the activation of executioner 
caspases ( caspase-3 and -7) in HepG2 cancer cells, which was a solid evidence for 
the presence of apoptosis. None of the cleaved caspase-3 or -7 was detected in Hs68 
normal cells. It suggested the Cordyceps extracts could cause apoptosis in the liver 
cancer cells but not the normal cells. Also, the cleaved caspase-9 could not be 
detected which indicated apoptosis was not initiated through the intrinsic pathway. 
The cleavage of some other apical caspases should be evaluated cautiously in order 
to reveal the detailed mechanisms. 
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